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BONE LOSS QUANTIFICATION FOLLOWING EXTRACTION IN RATS: 
A FOUNDATION FOR GRAFTING AND REGENERATIVE STUDIES 
Emily S. Willett, D.D.S., M.S. 
University of Nebraska Medical Center, 2016 
Advisor: Richard A. Reinhardt, D.D.S., Ph. D. 
Background: Loss of the alveolar ridge width and height following extraction is well-documented 
and several techniques, including grafting, have been proposed to reduce bone loss. Purpose: 
To characterize the pattern of bone turnover and inflammation after extraction and to initiate a 
study of the effect of grafting and local administration of simvastatin (SIM). Methods: Thirty-two 
retired-breeder rats underwent extraction of the right maxillary first molar and standard surgical 
defect creation under inhalation anesthesia. The left side of each animal served as the 
unmanipulated control. Comparison of groups (n=8, ANOVA) was done at days 0, 7, 14, and 28 
for alveolar bone height and width and for markers of inflammation and bone turnover by 
micro-computed tomography (µCT) and histology/ELISA. Seventeen additional specimens had 
the defects grafted with either bone mineral matrix (BMM) or a BMM+SIM conjugate. Results: 
µCT and histologic analysis demonstrated extraction-induced bone loss is most evident on the 
palatal (p < 0.001) and interproximal (p < 0.05) aspects of the socket. After the first week, a 
more intense inflammatory reaction corresponded to a reduction in alveolar bone height in the 
interproximal areas and alveolar bone height and width on the palatal aspect (p < 0.05). 
Increased numbers of osteoblasts were evident at the periphery of the socket at later time 
periods, particularly in the grafted specimens. BMM+SIM also reduced inflammation at 28 days 
(p < 0.001) and enhanced ridge width (p < 0.001). Conclusions: The standard defect used in the 
current study paralleled human post-extraction alveolar bone loss and defect grafting partially 
preserved bone.   
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INTRODUCTION 
The field of dentistry has historically been concerned with the lasting effects of tooth 
loss, and increasingly so considering advancements in surgical and non-surgical procedures to 
replace the missing structures. Extraction of teeth routinely involves creation of a bony defect 
and associated bony and soft tissue changes. Alveolar bone is a tooth-dependent structure and 
extraction of teeth results in compensatory fill of the extraction site as well as a well-
documented dimensional change of the alveolar ridge in width and height (Van der Weijden et 
al. 2009). After tooth extraction, there is a progressive and substantial reduction in the height 
and width of the bone in the immediate area of the extraction socket (Sun et al. 2013; Sadeghi 
et al. 2016). All of this occurs in an environment laden with bacteria capable of inducing variable 
amounts of inflammation. Many fields of dentistry are heavily invested in the field of research to 
preserve and enhance the alveolar bone and associated periodontal structures.  
Tooth extraction is a frequent occurrence and consistently leads to conformational and 
bone quality changes in the tooth socket and surrounding alveolar bone (Van der Weijden et al. 
2009). Specialists and general dentists alike are faced with the challenges that alveolar defects 
present in achieving a stable and esthetic result following compensatory tooth movement or 
prosthetic replacement. While post-extraction changes in alveolar bone are well described, cost-
effective models to dissect the impact of inflammation and grafting or pharmacological 
interventions are lacking. Understanding the healing process of bony contour changes and 
molecular and cellular responses of extraction sites will better enable clinicians to predict and 
modify the biologic response during healing. Refining a model to better define the role of 
inflammation on the process of healing following extractions will strengthen the foundation of 
knowledge and will provide a basis for future studies of modifications of the process using  
pharmacologic interventions. 
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The current study was designed to evaluate alveolar bone dimensions and bone quality 
changes after extraction in rats both with and without post-extraction grafting procedures. 
There were two parts to the current study. Part I involved extraction of a maxillary right molar 
and creation of a standard-sized defect, then prospective evaluation of the healing pattern over 
a four week period. Part 2 involved extraction of the maxillary right molar and a subsequent 
grafting of the site using the bovine non-antigenic, porous bone mineral matrix (BMM) (BioOss®, 
Geistlich Pharma North America, Inc.) both alone, and infused with simvastatin. Grafting was 
done with the benefit of filling the defect and providing a scaffold for eventual bone fill with the 
proven effect of decreasing the loss of the alveolar ridge following extraction (Wood & Mealey 
2012). The local administration of simvastatin has the effect of stimulating local bone formation 
(Thylin et al. 2002; Stein et al. 2005). The hypotheses were that analysis by micro-computed 
tomography (µCT) would demonstrate a significant reduction in alveolar bone dimensions and 
volume following extraction, and that analysis by histological sections and ELISA would indicate 
a concurrent inflammatory process correlated with loss of alveolar bone. In a proof-of-principal 
study, the hypothesis was that addition of mineral matrix to the socket will preserve alveolar 
bone and serve as a method to test future grafting compounds and pharmacological 
interventions.   
  
3 
 
LITERATURE REVIEW 
Tooth Extraction 
 Many studies have been conducted concerning extraction healing and various 
pharmaceutical and chemical applications to modulate the bone and soft tissue response 
(Araujo & Lindhe 2005; Tan et al. 2012; Tomlin et al. 2014). Extractions are among the most 
routine dental procedures (Van der Weijden et al. 2009; Tan et al. 2012) and are commonly 
prescribed in a variety of clinical scenarios like fracture, non-restorable decay, failed root canal 
treatments, and advanced periodontitis. Many fields of dentistry are heavily invested in the field 
of research to preserve and enhance the alveolar bone and associated periodontal structures. 
Millions of teeth are extracted annually, and most without regard for alveolar ridge 
maintenance (Moya-Villaescusa & Sanchez-Perez 2010). Alveolar bone is a tooth-dependent 
structure and its shape and volume are determined by dental influences like morphology of the 
teeth and tooth position upon eruption (Araujo & Lindhe 2005; Avila-Ortiz et al. 2014). It has 
been well-documented that with the removal of teeth, the adjacent alveolar bone undergoes 
significant atrophy. There are significant dimensional changes that occur in the early phases of 
healing, particularly in the first three months (Ashman 2000; Schropp & Isidor 2008; Tomlin et 
al. 2014). Bone loss of alveolar ridges after extraction complicate the treatment options 
following extraction. It is essential to have sufficient alveolar bone volume and adequate tissue 
contours for a functional and esthetic restoration (Avila-Ortiz et al. 2014; Tomlin et al. 2014). 
Appropriate pre-extraction and pre-prosthetic planning is essential to maintain the alveolar 
ridge to an adequate degree for replacement of the tooth by implant or other prosthetic 
intervention (Seibert & Salama 1996). Grafting of the extraction site immediately following the 
removal of the tooth has been proven in humans to reduce the amount of bone loss in the area 
as compared to ungrafted control sites (Araujo & Lindhe 2005; Nevins et al. 2006).  
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Normal Healing Response/Alveolar Bone Changes  
The removal of a tooth from its alveolar housing triggers a distinctive cascade of 
anatomical and physiological events that typically result in significant anatomic changes and 
decreases in the contours of the alveolar bone (Van der Weijden et al. 2009; Kuroshima et al. 
2014; Tomlin et al. 2014). After tooth extraction, there is generally a lack of soft tissue to cover 
the socket and any associated defect, thus the area must heal by secondary intention (Tan et al. 
2012). The initial stages of healing are marked by an increase in soft tissue volume by cell 
proliferation and a soft tissue covering will develop to close off the surgical area (Tan et al. 
2012). The process of healing following extraction in humans proceeds in a predictable pattern, 
involving both cellular and tissues changes (Tomlin et al. 2014). Moya-Villaescusa and Sanchez-
Perez (2010) described a process involving the following: immediately post-extraction the socket 
fills with blood as a result of vessel ruptures from the surrounding periodontal ligament and a 
severing of the blood supply to the tooth directly. In the first 24 hours, the collection of 
damaged cells and proteins from the wound initiate a series of cellular events leading to the 
formation of a fibrin network that traps platelets, establishing a clot. The clot is subsequently 
replaced within one week with granulation tissue (Pagni et al. 2012). There are additional 
biological events that characterize the healing of the extraction socket, namely the healing 
process called “corticalization”, where a bridge of hard tissue will cover the margins of the 
extraction socket and proliferative and resorptive events will lead to the development of a wall 
of cortical bone, although with reduced height and width (Moya-Villaescusa & Sanchez-Perez 
2010). It has been shown that osteoclasts emerge from the remaining crestal bone to resorb 
damaged bone, reducing the inflammatory reaction in the socket, which is required to progress 
through the wound healing process (Kuroshima et al. 2014). Socket healing is characterized by 
the migration of epithelium over the inflammatory granulation tissue to effectively cover the 
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wound and protect the clot. The granulation tissue is progressively replaced with connective 
tissue which becomes the provisional matrix of densely packed mesenchymal cells with fibers, 
blood vessels and woven bone (Trombelli et al. 2008; Pagni et al. 2012). The immature woven 
bone is then progressively replaced by lamellar bone and corresponding marrow spaces by 
progressive mineralization, demonstrating modeling of the extraction socket (Trombelli et al. 
2008). The hard and soft tissue changes continue in parallel processes with the changes in the 
alveolar ridge dimensions as modeling occurs, but remodeling of the socket continues after de 
novo bone formation in the extraction socket and bony defect areas (Madden & Caton 1994).  
The most significant dimensional changes are recognized in the early phase after 
extraction, with marked osteoclastic activity to resorb the crestal region of the alveolar bone, 
most notably in the buccal crestal bone (Araujo & Lindhe 2005; Sun et al. 2013). Tan et al. 
demonstrated a pattern of alveolar bone changes in vertical and horizontal dimensions that are 
most rapid in the initial six months after extraction, with a gradual reduction thereafter for up to 
five years. It has been concluded that the alveolar bone around the extraction site is resorbed in 
two overlapping phases: Phase 1 is marked by the resorption of the bundle bone that has a role 
in surrounding the teeth and its replacement with woven bone, demonstrated by a marked 
reduction in crestal height. Phase 2 includes resorption on the outer surfaces of the alveolar 
process, resulting in a reduction of bone width (Araujo & Lindhe 2005; Pagni et al. 2012). A 
systematic review of the studies of the alveolar dimensional changes post-extraction found the 
greatest change in the clinical loss of width (Van der Weijden et al. 2009). Human and animal 
studies have demonstrated that the buccal plate is resorbed to a greater degree than the palatal 
or lingual aspects because it is generally thinner (Huynh-Ba et al. 2010; Sun et al. 2013). The 
normal healing response is characterized by a significant decrease in the quality and quantity of 
alveolar bone and by a collapse in the surrounding gingival architecture (Steiner et al. 2008). 
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There is vertical and horizontal bone loss associated with the extraction-induced alveolar bone 
loss. Loss of the buccal plate in humans is the most dramatic post-extraction alveolar change 
because it is comprised of bundle bone and is thinner than the palatal or lingual plate (Jamjoom 
& Cohen 2015).  
Relevant Animal Models for Study 
 According to previous studies, small animals (e.g. rats, hamsters, rabbits) are excellent 
models for the evaluation of extraction healing and various interventions. The physiology of 
such small animals is not as similar to humans as larger animals, but there is a larger ethical 
concern and a significantly greater cost to canines and non-human primates (Madden & Caton 
1994; Struillou et al. 2010). Evaluation of alveolar bone healing following extractions and various 
manipulations has been done in various animals, including non-human primates, canines, 
ferrets, rabbits, and rats (Bodner et al. 1991; Devlin 2000). Using rats provides a more cost-
effective method with advantages for ease of housing and handling, making it possible to carry 
out studies with numbers necessary for statistical analysis (Struillou et al. 2010). Rats are the 
most extensively-studied rodent for research regarding the periodontium and various surgical 
techniques (Bodner et al. 1991; Struillou et al. 2010). Retired-breeder Sprague-Dawley rats were 
chosen for the current study to eliminate the potential for growth to influence the results. 
Sprague-Dawley rats were used to roughly standardize the size and metabolic activities of the 
specimens, and because of the extensive use of Sprague-Dawley rats in dental research 
(Struillou et al. 2010; Yang et al. 2015).  
The rat model of post-extraction bone modeling has shown general similarities to the 
human model from a physiologic perspective, but, in general, rats have a faster regeneration of 
oral tissues than humans (Schropp et al. 2003; Wu et al. 2008). Previous studies have indicated 
that there can be as much as 50% loss in the bucco-lingual dimension occurring after 12 months 
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in humans (Madden & Caton 1994; Schropp et al. 2003; Pagni et al. 2012). A radiographic and 
histologic study of the healing extraction site in rats demonstrated that no changes were 
observed in the socket between the 28 and 60 day observation points, thus a 28 day period was 
chosen for the current study (Bodner et al. 1993). In humans, the most rapid alveolar resorption 
occurs in the first six months following extraction and continues throughout life at a rate of 0.5-
1.0% (Pagni et al. 2012). Comparable studies on the timing and percentage of alveolar bone loss 
following extraction in rats have not been done. Other studies evaluating alveolar bone 
dimensions using a rat model had evaluation time points of significantly less time, with the 
greatest reported time period being 12 weeks (Wu et al. 2008; Yang et al. 2015). In addition, 
extraction of the largest rat tooth (the maxillary first molar), leaves five small sockets 
corresponding to the five roots of the tooth of irregular shape. Creation of a single larger socket 
would be more clinically relevant and can be done by manipulation of the socket after 
extraction using a dental hand piece and round bur, as was done by Hile et al. (2005) to create a 
standardized defect. 
A 2008 study by Wu et al. evaluated the effect of simvastatin (SIM) on the alveolar bone 
following extraction and found that on the non-intervention side, a measurable loss of bone 
occurred over the 12 weeks of evaluation. This study evaluated the bone level by capturing a 2D 
image to evaluate interproximal bone and measurements were obtained between two 
standardized points. Bone mineral density was also measured in this study and was obtained by 
dual-energy X-ray absorptiometry (DXA) measurements and Lexxos (DMS, France) software. The 
four week animals demonstrated a gradual reduction in relative (no units of measure published) 
alveolar bone height measured on 2D radiographs from 0.996±0.004 (p=0.304) at week 1 to 
0.987±0.004 (p=0.017) at week 2 to 0.906±0.034 at week 4 (Wu et al. 2008). This study also 
reported the bone mineral density changes for the unmanipulated side that served as the 
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control over time as a gradual increase: 6.775±0.042 (p=0.106) at week 1, 7.053±0.032 
(p=0.076) at week 2, and 7.101±0.014 (p=0.039) at week 4 following extraction of a mandibular 
tooth. DXA is considered the gold standard for BMD measurements and BMD an important 
parameter to evaluate the amount of bone formation and degree of calcification of the newly 
formed bone (Adams 1997; Wu et al. 2008).  
Fine et al. (2009) also measured alveolar bone level changes in rats, but focused on 
induced periodontitis. Their method for measuring bone level changes involved 2D radiographs 
to measure from the CEJ to the alveolar bone crest to determine area of bone loss, linear bone 
loss, and bone loss by a direct visual measurement of the interproximal region after a 12 week 
study period. To calculate the total area and linear measurements for this study, six regions 
were traced from the CEJ to the alveolar bone crest to include the furcation areas and 
interproximal areas between M1, M2, and M3. The investigators (Fine et al. 2009) for this study 
did additional research to determine baseline bone loss but the bone loss was cumulative across 
six measurement sites and thus cannot be applied to the current study (Schreiner et al. 2011).  
Interventions and Grafting Methods 
 Acknowledging the prevalence of tooth extractions in dentistry and their pattern of 
alveolar bone contour changes and loss of dimension, it is important to focus on the options 
available to minimize the destruction that occurs. Several surgical techniques have been 
proposed to reduce the loss of alveolar bone (Pagni et al. 2012). After the extraction of teeth, 
the periodontium (gingiva, connective tissue, cementum, periodontal ligament, alveolar bone) 
undergoes significant changes, most clinically significant of which is the loss of alveolar bone by 
bone modeling (Tomlin et al. 2014). More posterior teeth, or larger teeth, and more traumatic 
extractions result in more bone loss (Tomlin et al. 2014). A bone substitute is ideally 
biocompatible and is gradually replaced by new bone (Su-Gwan et al. 2001). Knowing that there 
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are significant dimensional changes that occur, particularly in the early phase after extraction 
(Araujo & Lindhe 2005), dentistry has become interested in various mechanisms of bone 
preservation. Such methods include the following: atraumatic extraction techniques, various 
bone grafting materials and methods, and tissue engineering methods. Although autogenous 
grafting material is the gold standard for bone grafting because of the osteogenic potential and 
no risk of graft rejection, there is significant site morbidity (Darby et al. 2008). There are many 
options when choosing a graft material, including the following: autogenous bone, 
demineralized freeze-dried bone allografts (DFDBA), xenografts like Bio-Oss, bioactive glass, 
hydroxyapatite and calcium sulfate (Darby et al. 2008). Utilizing bone grafts and bone 
substitutes provide the clinical advantages of filling the defect and providing a scaffold for 
eventual bone fill with the proven effect of decreasing the loss of the alveolar ridge following 
extraction (Wood & Mealey 2012). 
Clinicians prefer graft materials that can be easily manipulated (Kim et al. 2016). 
Deproteinized bovine bone (DBB) material, commonly known as bone mineralized matrix (BMM) 
or its brand name, Bio-Oss, is the most commonly used xenograft (Tomlin et al. 2014). BMM can 
be hydrated to form a slurry or a gel prior to use. It has been found that hydration of graft 
materials like Bio-Oss promotes the environment of the graft site (Pietrzak 2006). BMM is a 
popular graft material due to its biocompatibility and osteoconductive properties (Jensen et al. 
1996; Skoglund et al. 1997; Su-Gwan et al. 2001). The composition of BMM is the spongiosa of 
bovine bone cleansed of organic matrix, or deproteinized, and denatured so that is it biologically 
compatible to serve as a xenogenic bone graft (Pinholt et al. 1991). A study of BMM implanted 
in male rats concluded that an inflammatory reaction occurs with implantation subcutaneously 
and in the maxilla (Pinholt et al. 1991), while a previous study identified the BMM graft 
demonstrated the best bone formation and organization of the graft itself as compared with 
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particulate dentin and plaster in various combinations (Su-Gwan et al. 2001). A human study 
evaluating BMM as graft material identified that the graft material is slowly degraded rather 
than resorbed and the new bone was present close to the implant particles and ossification 
centers were identified centrally (Skoglund et al. 1997).  
Role and Interaction of Inflammation in Healing 
 Many studies have documented the significance inflammation plays during the wound 
healing process and the inflammatory reaction has been described as the second of four distinct 
wound healing phases (Guo & Dipietro 2010). Inflammation is a critical and normal part of the 
healing process and the cells of the inflammatory process are critical in removing contaminants 
and micro-organisms (Guo & Dipietro 2010).  
In the inflammatory process, the cellular products, like prostaglandins (PG), and the 
pathways they mediate play a critical role in the physiological response for wound healing. 
Prostaglandins are lipid mediators that act in autocrine and paracrine functions and can mediate 
a number of physiological and pathological conditions, both stimulatory and resorptive (Pountos 
et al. 2012).  Key markers of inflammation include PGE2, which is one of the most abundant 
prostaglandins in the body (Funk 2001).  PGE2 is ubiquitously produced and is constantly present 
at low levels, but the PGE2 level increases immediately in acute inflammation to act as a 
chemoattractant for leukocytes and other immune cells (Ricciotti & FitzGerald 2011). Heavily 
involved in the classical signs of inflammation, including redness, swelling, and pain, PGE2 acts to 
mediate the inflammatory process (Funk 2001).  
Bone healing is one of the most complex physiological cascades of events, with local and 
systemic cytokines and other mediators directing the outcome (Pountos et al. 2012). 
Considering the influence of inflammation on healing, specific important mediators of 
inflammation, like PGE2, can be quantified at various time points to determine the relative 
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degree of inflammatory response. PGE2 serves many important physiologic functions, depending 
on its level in tissues.  Depending on levels, PGE2 is involved in bone resorption at high levels and 
bone formation at lower and intermittent levels (Pountos et al. 2012). Since PGE2 is a product of 
the COX-2 pathway, inhibition of that pathway by pharmaceutical interventions may have an 
effect on the physiological outcome of PGE2 pathways (Bradley et al. 2007; Lee et al. 2011). 
Following grafting procedures, an inflammatory response is stimulated and preliminary studies 
demonstrated that there is a potential negative effect for graft survival if the mediators of 
inflammation are inhibited (Preston et al. 2007). Many animal studies, but very few human 
studies, have been conducted to evaluate the role of nonsteroidal anti-inflammatory drug 
(NSAID) use and suppression of the inflammatory response and the results of the animal studies 
are somewhat mixed (Pountos et al. 2012). It has been hypothesized that in patients taking anti-
inflammatory medicines like NSAIDs after bone grafting procedures will have less successful 
clinical outcomes, as compared to individuals who do not inhibit the inflammatory response, 
based on the significance of prostaglandins, and specifically PGE2, in the healing process 
(Pountos et al. 2012).  
The bone healing response has been evaluated in light of the concurrent administration 
of simvastatin, which has demonstrated bone anabolic properties based on the ability of the 
statin to stimulate endogenous BMP-2 for osteogenesis (Mundy et al. 1999). Other studies have 
further evaluated this link between statins and bone formation and have confirmed that the 
local administration does stimulate bone growth in rodent populations (Thylin et al. 2002; Stein 
et al. 2005). Those studies reported local inflammation around injection sites and thus 
interventions to reduce the swelling by administration of the NSAID indomethacin and, 
therefore, interruption of the COX and PG pathways resulted in nearly eliminating the statin-
induced new bone growth. Rodent studies have demonstrated that NSAIDs that inhibit PGE2 
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interrupt both bone healing and normal bone growth (Yugoshi et al. 2002). Another study that 
evaluated the role of the PG pathway with simvastatin-induced oral bone growth in rats found 
that higher levels of PGE2 in the first week enhanced the bone growth (Lee et al. 2011). Bradley 
et al. (2007) demonstrated in a rat model that locally administered SIM stimulates bone 
formation, but that effect is diminished when inflammation is inhibited pharmacologically.  
Evaluation Methods  
I. µCT 
 Micro-computed tomography (µCT) is a valuable research and clinical tool to evaluate 
mineralized tissues by two-dimensional and three-dimensional parameters. Linear 
measurements of alveolar height and width as well as volumetric measurements of bone quality 
and quantity, like bone density and trabecular separation, can be accomplished with µCT. A 
2007 study of mature Sprague-Dawley rats evaluated the linear and volumetric parameters of 
alveolar bone by µCT (Park et al. 2007). In this study, they were able to develop methods to 
accurately and reproducibly quantify alveolar bone as a way to standardize bone measurements 
in scenarios of disease progression or regeneration attempts. Park et al. (2007) utilized an 
experimental bone loss model to validate the use of µCT for bone imaging. Linear and 
volumetric measurements were obtained in this study for the clinical models of disease, trauma, 
and regeneration, but the results were not reported for bone level. The methods for obtaining 
the linear measurements were to measure in the interdental regions of M1-M2 and M2-M3 
from the CEJ to ABC and orienting the image to view the CEJ and root apices (Park et al. 2007). 
Bone volume, bone mineral density, and bone volume fraction were volumetric measurements 
obtained from the ROI captured, although the baseline values were not reported (Park et al. 
2007). Linear measurements are typically taken on 2D radiographs, but the 3D images can be 
manipulated in such a way as to standardize their projection and linear measurements can be 
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obtained. This study split the rats into two groups: a bone loss group which received 
Porphyromonas gingivalis LPS injections, and a regeneration group received surgical 
osteotomies that were then covered with seeded PLGA scaffolds, described previously by Jin et 
al. (2004). Comparing baseline to 8 weeks of the LPS-injected group, the interdental bone 
regions demonstrated significant differences in cementoenamel junction (CEJ) to alveolar bone 
crest (ABC) distance, concurrent with periodontal disease-induced bone loss. There was no 
difference between baseline and 8 weeks with the control group with no disease. In the 
regenerative therapy group, exposure of the tooth root with a cell-seeded PLGA barrier resulted 
in less root exposure by bone loss than the control group. In all groups, the amount of bone 
changes were evident on both 2D and 3D images, and volumetric measurements of bone 
volume, bone mineral content, and bone mineral density were obtainable. There was high 
reliability and reproducibility and, thus, the authors felt the proposed method of 3D µCT was 
valuable to assess periodontal osseous changes over time.  
There is a paucity of studies that have evaluated the changes in rat alveolar bone 
following extraction using µCT. A 2014 study of rats comparing bisphosphonate and parathyroid 
hormone treatments using µCT demonstrated the usefulness of the technology and also 
measured the vertical alveolar bone loss after extraction, but did not report the baseline bone 
loss values prior to pharmacologic intervention (Kuroshima et al. 2014). This study evaluated the 
sockets at 10 days following extraction because of the pattern of healing in rats that 
demonstrates epithelial coverage of the wound and woven bone filling the bottom half of the 
socket.  
II. Histological Analysis 
  The distinct pattern of wound healing can be characterized by histologic analysis of the 
process at distinct time points. The characterization of the healing process has been well 
14 
 
described in various studies and is consistent across species (Kim et al. 2012). The normal 
healing process generally progresses through a series of distinctive phases, and the 
inflammatory infiltrate and bone surface response has been characterized in a rat model (Kim et 
al. 2012). From the sections, inflammatory infiltrate area, cell types and bone surface osteoblast 
and osteoclast surfaces were measured at the periphery of the healing wound. After the initial 
blood clot formation, the inflammatory infiltration was rapid and the cells of an acute 
inflammatory reaction were present but diminish after about 10 days, coinciding with 
indications of bone turnover and new bone forming in the socket (Kim et al. 2012). Healing can 
be assessed histologically by looking at the quality (acute, mixed, or chronic inflammatory 
infiltrate) or the quantity (mild, moderate, or severe inflammation) of the inflammatory 
response in the area of interest. By evaluating the cells present in the inflammatory infiltrate, 
the inflammation can be characterized as acute with a predominantly neutrophilic infiltrate, 
chronic with a predominantly a lymphocytic infiltrate, or mixed with both a neutrophilic and 
lymphocytic infiltrate. The relative severity of the inflammatory response can be characterized 
using a numerical scale based on the histologic presentation (Kristensen et al. 2008).  
 In addition to the inflammatory reaction, the histological sections can reveal the relative 
bone surface activity and relative amount of bone turnover. The development of new bone on 
the periosteal aspect during healing has been seen in previous rat studies (Pietrokovski & 
Massler 1967; Todo 1968). By evaluating the bone surface for activity and quantifying the 
proportion of surface lined by osteoblasts or osteoclasts, relative surface activity or quiescence 
of the bone can be determined. The active bone cells can be identified histologically and 
microscopically. Osteoblasts are bone forming cells that contain one nucleus and are plump cells 
found in a single layer on the surface of the bone (Clarke 2008). On the other hand, osteoclasts 
are the only cells that resorb bone and they can be microscopically identified based on their 
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multinuclear appearance and their presence on the surface of bone accompanied by their 
resorptive area or Howship’s lacunae (Clarke 2008). Any area of the bony surface not occupied 
by an active osteoblast or osteoclast is said to be in a stage of quiescence and is not actively 
undergoing formation or resorption.  
In the first month of healing following extraction, the normal histological sequence of 
wound healing is expected to progress without incident. A previous study of the bone density 
and histological changes following extraction in rats demonstrated distinctive phases of healing 
(Bodner et al. 1993). Bodner et al. (1993) identified a bone formation phase occurring at the 7 
and 14 day time periods and a bone remodeling phase with maturation of the young bone and 
modeling of the alveolar ridge at the 28 day periods.  
A study of maxillary molar extraction sockets in ovariectomized rats evaluated the 
healing process at various time periods with SEM and light microscopic histologic analysis 
(Shimizu et al. 1998). The 7 day and 30 day time periods of the above study aligned with the 
current study. At 7 days after extraction, the SEM analysis revealed Howship’s lacunae of 
resorptive areas mainly on the buccal aspect, but also on the palatal aspect, and commonly in 
the deeper regions of the extraction socket. The study also demonstrated subtle areas of bone 
formation and thin lamellar bone was evident. At 30 days following extraction, the extraction 
sockets were filled with lamellar bone, but there were significant resorptive areas on the palatal 
aspect (Shimizu et al. 1998). In this study, bone resorption was more evident on the palatal 
aspect than on the buccal aspect of the extraction socket (Shimizu et al. 1998). The conclusions 
of the Shimizu et al. study revealed that bone formation and bone resorption take place at 
distinct sites, but the processes are closely related and coupled so that they take place adjacent 
to one another (Shimizu et al. 1998).    
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A historic study of male rats evaluated a healing mandibular molar extraction socket by 
histologic, radiographic, and histometric methods at various time points (Guglielmotti & Cabrini 
1985). The histologic findings from the above study demonstrated that at 0 days, the socket was 
filled with blood coagulum and surgical debris, at 7 days, the internal and lingual crest of the 
socket showed signs of resorption, at 14 days, the bone surfaces showed intense bone activity 
and at 30 days, the socket was filled with new bone and active osteoblasts were predominantly 
located on the alveolar ridge. This study evaluated the H&E stained socket at 40X magnification.  
A more recent study evaluated male mature rats who were subjected to mandibular 
molar extraction by histometric analysis at 3, 7, 10, and 14 days following extraction (Giorgetti 
et al. 2012). The control group underwent only mandibular molar extraction with no 
intervention or treatment and experienced an increase in mineralized tissue and a decrease in 
nonmineralized tissue at the fundus of the socket between 7 and 14 days (Giorgetti et al. 2012). 
In this study, new bone formation was evident at 7 and 14 days and was seen as bone 
trabeculation in the extraction socket.   
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METHODS AND MATERIALS 
Pilot Study 
 Prior to the core study, a pilot study was undertaken to refine the extraction and defect 
creation techniques, evaluate the effectiveness and repeatability of the current study’s 
measurement techniques, become familiar with the protocol, and confirm that there is bone 
loss in the extraction site compared to the contralateral side at a period of 28 days, or 4 weeks, 
following the surgical procedure. Four retired-breeder Sprague Dawley rats (Harlan Teklad, 
Madison, WI) were used as a pilot study group. Rats were acclimated prior to experimental 
procedures for one week and were treated and housed in the University of Nebraska Medical 
Center College of Dentistry Animal Facility, Lincoln, NE, under approval of the University of 
Nebraska Medical Center Institutional Animal Care and Use Committee (IACUC #14-080-10-FC). 
Retired breeder rats were chosen to eliminate the effect of growth on the alveolar bone 
changes and to standardize the metabolic activities. Each rat was weighed prior to any 
procedure. The rats were all placed in a surgical group with a 28-day follow-up period planned. 
Adequate anesthesia was administered by inhalation of isoflurane, followed by a local 
anesthetic injection of 0.2 cc of 3% carbocaine in 1:20,000 neo-cobefrin into the right facial 
vestibule as it demonstrated effectiveness in previous rat studies (Killeen et al. 2012). In minor 
surgeries, this anesthesia method has proven effective in the maxilla.   
Extraction of the maxillary right first molar was accomplished using a modified dental 
carver (1/2 Hollenback carver, Hu-Friedy, Chicago, IL, USA) to incise the gingival attachment and 
a modified explorer (2 Explorer, Hu-Friedy, Chicago, IL, USA) was used to luxate the tooth 
mesially. During the procedure, a small flap was reflected using the periodontal probe so that 2 
mm of facial bone was partially exposed. A standardized bone defect was created using a #6 
round dental bur of 1.8 mm diameter under water irrigation and evacuation, to a depth 2 mm 
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from the cementoenamel junction of the maxillary right second molar. The maxillary left first 
molar served as the unmanipulated control for the study. The surgical flap was closed using 
cyanoacrylate adhesive (PeriAcryl 90, GluStitch Inc, Delta, BC, Canada). A 0.01 mg/kg dose of 
buprenorphine was administered subcutaneously after the procedure. All animals were 
euthanized 28 days after the initial surgical procedure and the palates were harvested and 
placed in 10% formalin for fixation prior to evaluation. All animals were evaluated by µCT and 
histologic assessment to confirm that bone loss occurred and to identify the appropriate 
thickness and location for the histologic sections. 
Results from the pilot study confirmed the loss of alveolar bone with extraction and 
surgical defect creation. Loss of alveolar bone on the palatal aspect was more predictable 
because surgical trauma or harvest frequently caused fracture of the buccal cortical plate. The 
technique for anesthesia was modified due to right ocular hemorrhage evident in the animals 
after the procedure, so that the needle was inserted only to a depth of 2 mm and only 0.1 cc of 
3% carbocaine in 1:20,000 neo-cobefrin was administered. In addition, isoflurane inhalation 
anesthesia was adequate, with no animals requiring the intramuscular ketamine/xylazine 
injection.  
There was often communication between the socket and the maxillary sinus upon 
evaluation of the pilot group; therefore, a #4-round bur with a 1.4 mm diameter was proposed 
to create the surgical defect and remove residual roots. The pilot study confirmed that a 28 day 
period was sufficient to see alveolar bone changes, and that interim periods would serve as an 
opportunity to evaluate morphologic, biochemical, and histologic changes. Time periods of 0 
days, 7 days, 14 days, and 28 days were used because of the ability to evaluate the healing 
process over time by µCT and histological analysis.  
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Core Study 
 Fifty mature (10 to 12 month old) retired-breeder female Sprague Dawley rats were 
chosen for this study (Harlan Teklad, Madison, WI). The core study was split into two parts: Part 
I consisted of 33 rats and Part 2 consisted of 17 rats. The rats were allowed to acclimate for one 
week prior to the procedure. All animals were treated and housed at the University of Nebraska 
Medical Center College of Dentistry Animal Facility under the supervision of the Institutional 
Animal Care and Use Committee (IACUC #14-080-10-FC), and the study was conducted in 
accordance with the Helsinki Declaration of 1975, as revised in 2013.  
Groups 
 Rats were divided into six groups: Groups 1-4 were designated to Part 1 of the core 
study and Groups 5-6 were designated to Part 2 (Table 1) of the core study. All extractions were 
done on the maxillary right first molar. Groups 1-4 received extraction and surgical defect 
creation only. Group 1 was euthanized by CO2 asphyxiation immediately after the extraction and 
surgical defect creation (day 0), Group 2 was anesthetized, sockets created, then euthanized at 
7 days, Group 3 was anesthetized, sockets created, then euthanized at 14 days, and Group 4 was 
anesthetized by inhalation and sockets created and were sampled for socket fluid at 7 days, 14 
days, 28 days and euthanized at 28 days. Groups 5 and 6 were treated like Group 4 with the 
extraction, defect creation, socket fluid samples at 7 days, 14 days, and 28 days; however, two 
modifications were made: Group 5 sockets were grafted with a slurry of bovine bone mineral 
matrix small granules (BMM, Geistlich, Bio-Oss, Princeton, NJ, USA) and packed into the socket 
prior to the surgical wound being closed using cyanoacrylate adhesive (PeriAcryl 90, GluStitch 
Inc, Delta, BC, Canada), and Group 6 sockets were grafted with approximately 0.2 mg 
simvastatin absorbed to BMM (BMM+SIM) conjugate slurry packed into the socket prior to the 
surgical wound being closed with cyanoacrylate adhesive. For all groups, the left maxillary right 
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molar served as the unmanipulated control. All groups had at least 8 specimens, and groups 4 
and 6 had 9 specimens due to extra animals being delivered to the facility. 
Anesthesia/Euthanasia 
 Anesthesia was induced by placing the rats into an anesthesia induction chamber with 
1-4% isoflurane/100% O2 (1 to 3 L/min). The animal’s pattern of breathing was used to 
determine the depth of anesthesia. Following removal from the incubation chamber, a nose 
cone was placed over the rat’s nose and 0.5 to 2% isoflurane/100% O2 (0.5 to 1.0 L/min) was 
used to maintain anesthesia during the procedures. Local anesthesia was achieved by local 
infiltration into the right maxillary vestibule adjacent to the first molar of 0.1 cc of 3% 
carbocaine in 1:20,000 neo-cobefrin with the needle inserted to a depth of 2mm. All animals 
were weighed following anesthesia induction and prior to all procedures to monitor weight gain 
or loss. Following the anesthesia, injections, and extraction, the rats were monitored until 
awake and normal movement resumed. After the surgical procedure, Group 1 was euthanized 
immediately by CO2 asphyxiation and decapitation, Group 2 was euthanized at 7 days, Group 3 
was euthanized at 14 days, and Groups 4-6 were euthanized at 28 days.  The palates and 
maxillary alveolus were separated from the rest of the skull and placed in 10% formalin for 
storage prior to µCT analysis. 
Graft Preparation and Application 
 Part 2 of the study consisted of evaluation of the pharmacomanipulation of the socket 
as an intervention for bone preservation. This portion of the study was completed to determine 
if a bovine bone mineral matrix graft (BMM) with or without a simvastatin-pyrophosphate 
conjugate shown to stimulate bone formation in experimental periodontitis, can stimulate bone 
formation. BMM was selected as the graft material based on its biocompatibility, its 
osteoconductive properties, and its widespread use as a grafting material in dentistry (Darby et 
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al. 2008). The graft material was supplied in a small granule size (0.25- to 1.0-mm particle size) 
and it was absorbed to a simvastatin-pyrophosphate conjugate. Preparation of 1.5 mg 
simvastatin (SIM)-pyrophosphate (PPi) conjugated bone graft per 0.1 g BMM involved 1 g 
bovine-derived bone mineral particles, BMM, (BioOss®, Geistlich Pharma North America, Inc.) 
incubated with 5 ml (SIM-PPi) solution (10 mg/ml) in a tube rotator at room temperature for 20 
minutes. The unbound SIM was removed and quantified by calculating the amount of SIM-PPi in 
the supernatant after centrifugation at 3000 rpm for four cycles at 5 minutes per cycle, after 
which the free SIM remaining in the supernatant was removed by pipette. The concentration of 
SIM-PPi in the supernatant was determined by measuring ultraviolet absorbance at 238 nm. The 
usable BMM+SIM-PPi conjugate with 1.5 mg simvastatin per 0.1 g BMM bone graft small grains 
was obtained after lyophilization for 24 hours. The BMM+SIM-PPi conjugate was stored on dry 
ice prior to use to eliminate any risk of degradation. At the time of extraction and graft 
placement, it was determined that the particles were too large for the small bone defect, so 
further crushing of the particles was accomplished by mortar and pestle and only 0.01 g of graft 
material was placed in the defect. One half of the animals in Part 2 of the study received only 
the BMM graft, but the extraction, defect creation, grafting methods, post-operative care, and 
evaluation methods were consistent regardless of the type of graft placed. The graft materials 
were hydrated in sterile deionized water for ease of placement. The extraction defect and graft 
material were covered with cyanoacrylate adhesive in the same fashion as in Part I. Placement 
of cyanoacrylate cement was repeated one week later during socket fluid sample collection to 
aid in the retention of the graft material.  
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Evaluation Methods 
I. µCT Measurements 
Evaluation of bone changes was done by µCT analysis. Studies have found that   
extraction in rats leads to alveolar bone morphologic changes that can be assessed by 
tomograms and three-dimensional imaging (Alikhani et al. 2016). Each maxilla was scanned with 
a high-resolution system (SkyScan 1172, Bruker microCT, Kontich, Belgium) with the x-ray tube 
voltage at 70 kV, the current at 141 µA, with a 5 mm-thick aluminum filter, for a fixed exposure 
time of 580 ms. The images were reconstructed into a 3D-structure with a pixel size of 8.71 um. 
The x-ray projections were obtained in multiple frames with each rotation at a 0.7˚ interval with 
a scanning angular rotation of 180˚ and an average of five frames for each rotation.  
Two software programs were used to first orient the 3D images (DataViewer, Bruker 
microCT, Kontich, Belgium) and then a second software program was used to obtain the linear 
and volumetric measurements (CTAn, Bruker microCT, Kontich, Belgium). All specimens were 
initially oriented on three axes in the DataViewer software using the orientation lines (red, blue, 
green), corresponding to the three planes (Figure 1). The image orientation was manipulated for 
a coronal slice to measure the buccal and palatal alveolar bone and for a sagittal slice to 
measure the interproximal bone height.  
The coronal images were used that captured the best internal anatomy of mesial canals 
of the maxillary second molar, aligned with the line of best fit through the buccal and palatal 
cementoenamel junctions (CEJ) parallel to the horizontal orientation lines. The red line was 
centered through mesial canals of the maxillary second molar in the “transaxial” image as 
designated by the software, the blue line was oriented down the long axis of the tooth in 
“coronal” image, and the green line was aligned as the line of best fit through the buccal and 
palatal CEJ in the “sagittal” image (Figure 1).  The buccal bone height was from the mid-socket 
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by first finding the µCT slice that represented the first time the mesial aspect of M2 was visible 
and then advancing into the socket 0.557 mm to the point that reproducibly represented the 
area of interest, then the bone height was measured by recording the distance from the most 
superior and lateral aspect to the buccal alveolar crest (Figure 2). Additionally, the width of the 
buccal cortical plate was measured from the superior and lateral aspect and advancing in 0.25 
mm increments to the alveolar crest and then measuring the perpendicular width. The height 
and width of the palatal bone was measured using the same method as the buccal bone height 
on the same slice from the µCT data but from the most superior and mesial aspect that 
corresponded to the alveolar process of the maxilla. To measure total width, the mid-socket 
slice was used and the measurement was obtained by identifying the perpendicular line of 
greatest width buccal to palatal to the point 1.25 mm crestal from the most superior and lateral 
point of the buccal cortical plate. The socket total area was recorded from the same mid-socket 
slice and tracing the outline of all of the radiopaque area including the alveolar bone and tooth 
structure when present on the control side.  
For the sagittal view to evaluate the alveolar bone height mesial and distal to the 
maxillary second molars, the image was oriented in the DataViewer software using the 
orientation lines so that the green line intersected the palatal canals of the teeth present, the 
blue red line was placed equidistant mesial-distally between the palatal roots of the maxillary 
second molar, and the blue line was oriented as a line of best fit through the mesial and distal 
CEJ of the maxillary second and third molars (Figure 3). Using µCT and the measurement 
software (CTAn, Bruker microCT, Kontich, Belgium), the loss of vertical bone height was assessed 
from the CEJ to the crestal bone adjacent to the periodontal ligament space on the mesial and 
distal aspects of the maxillary second molars. The amount of interproximal bone loss was 
recorded on the mesial and distal aspect of M2 by tracing a line from the CEJ to the ABC parallel 
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to the root structure and recording the linear distance until the most crestal portion of alveolar 
bone present (Figures 4 and 5).  
The bone volume and density parameters of bone quality were also measured in the 
palatal crest areas using an image from the coronal slice. The region of interest (ROI) was 
determined by aligning the ROI rectangle to the most cervical location where a standard 
rectangular box (0.261 x 0.450 x 0.340 µm) could be placed (Figure 6). The ROI was then 
analyzed for the volumetric and bone quality measurements for the following parameters: mean 
bone mineral density (BMD), bone volume (BV), bone volume (BV)/trabecular volume (TV) or 
fraction of mineralized tissue in the ROI, and bone surface (BS)/trabecular volume (TV) for bone 
surface density (BSD). 
II. Histological Analysis  
 Following analysis by µCT, the specimens were decalcified using a 5% formic acid 
solution for at least 2 weeks at 4˚C. Each was then processed, blocked, and coronally sectioned 
for hematoxylin and eosin staining for conventional histological examination. At the palatal 
alveolar crest, the inflammatory infiltrate area, cell types and bone surface 
osteoblast/osteoclast presence were measured. At lower magnification (40x), the palatal area 
was captured using a light microscope and digital camera/software (ProgRes CapturePro; 
JENOPTIK Optical Systems, Jena, Germany). All specimens were initially interpreted by the 
primary investigator masked to experimental group and secondly by a masked experienced 
pathologist and any disagreements in the scoring were resolved by a masked third party. A 
qualitative assessment of the predominant inflammatory cell type present and relative degree 
of inflammation were made using a light microscope and the following scale modified from 
Kristensen et al. (2008), the inflammation as rated 0 to 3. The scoring criteria in the current 
study was defined as follows: 0 = no inflammatory cells present, no inflammation; 1 = few, 
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scattered inflammatory cells present, mild inflammation; 2 = multiple clearly present 
inflammatory cells present, moderate inflammation; 3 = massive presence of inflammatory cells, 
severe inflammation (Figure 7). Additionally, a qualitative assessment regarding the stage of 
inflammation was also made in the same manner and scored as either acute, mixed acute and 
chronic, or chronic, based on the predominant cell types present with acute inflammation 
characterized by neutrophilic infiltrate and chronic inflammation characterized by a 
predominantly lymphocytic infiltrate (Farb et al. 1999) (Figure 8). Histopathologic scoring for 
research is common and specimens are commonly grouped based on microscopic similarities of 
generalized properties for ease of comparison. Using the 40x magnification view, the general 
area of inflammatory infiltrate was evaluated. Roughly 600,000 µm of connective tissue area 
adjacent to the palatal crest was outlined and the internal area of inflammatory infiltrate was 
outlined and the percentage of inflammatory infiltrate was calculated (Figure 9). Measuring the 
relative activity of the bone surface in the palatal alveolar crest region was done using higher 
magnification (100x) to detect specific cells of bone turnover, osteoblasts and osteoclasts, on 
the bone surface. Osteoblasts were identified by containing one plump nucleus and found in a 
single layer on the bone surface, osteoclasts were identified as the cells with a multinuclear 
appearance adjacent to Howship’s lacunae, and quiescent surface was any bone surface area 
that was not undergoing bone turnover (Figure 10). Roughly 4000 µm of bone surface was 
analyzed and the relative proportions of that surface area that were lined by osteoblasts and 
osteoclasts were reported (Figure 11).  
III. ELISA 
 Socket fluid absorption samples were taken at weeks 1, 2, and 4 using an absorbent 
paper strip (Periopaper, IDE Interstate, Amityville, NY, USA). However, the healing process 
prevented consistent samples after the first week of healing. The samples were frozen at -80˚C 
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until all samples were collected so the measurements could be obtained at one time. The paper 
strips were eluted in 250 µL of PBS solution for 1 hour prior to following the protocol for the 
PGE2 ELISA monoclonal kit (Cayman Chemical, Ann Arbor, MI) and rat albumin ELISA kit 
(Innovative Research, Inc., Novi, MI) according to manufacturer instructions. The PGE2 samples 
were run at undiluted and 1:10 dilutions and the plate was read at the recommended 405 nm 
wavelength. The albumin samples were run at undiluted, 1:10 dilutions, and 1:100 dilutions and 
the plate was read at the recommended 450 nm wavelength. PGE2 levels were divided by the 
albumin level to standardize the relative amounts of PGE2 present due to the variability in the 
quantity of socket fluid sample collected. 
IV. Statistical Analysis 
A power analysis was conducted and demonstrated that 8 rats were needed to show 
greater than 30% increase in alveolar bone growth 80% of the time when testing at the 5% level 
of significance using various doses for simvastatin, an anti-inflammatory and bone anabolic 
agent which was the pharmaceutical intervention tested. Each group contained at least 8 rats 
and additional animals were added to groups 4 and 6 for a total of 9 rats in those groups 
because extra animals were sent during animal delivery. Specimens were coded by animal 
number and measured by one examiner without knowledge of group designation. The same 
examiner repeated these measurements on 10% of the original specimens 2 weeks after initial 
measurement. Analysis of variance was utilized for intergroup comparisons for all clinical 
measurements from the treatment and control sides at different postoperative time intervals. 
The difference in the measurements from the treatment side (right) after operation against the 
control side (left) from the same animal was computed. The one-sample t-test was used to 
evaluate whether significantly different values between the treatment side and the control side 
of the same animal existed between the experimental group and the corresponding intra-rat 
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control. The Spearman correlations were calculated to measure the correlation between the 
clinical measurements of bone loss and the inflammatory measurements. Differences between 
groups were analyzed using the Kruskal-Wallis test for non-parametric and non-normally 
distributed data. Results were reported as mean ± standard deviations, with the exception of 
the PGE2 data which were reported as mean ± standard error, and considered significant when p 
values were ≤ 0.05. When significant differences were found among groups (p≤0.05), pairwise 
comparisons between groups were analyzed using the Wilcoxon rank sum non-parametric 
method and p-values were adjusted using the Bonferroni method for multiple comparisons. The 
intra-class correlation coefficients (ICC) and its 95% confidence interval based on two-way 
random effects model and single measurements calculated assessed the reliability of the 
measurements.  
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RESULTS 
Part 1 
 The weight of the animals (Table 4) among groups was not different and no significant 
weight was lost in any group. No animals died prematurely during Part I of the core study and all 
animals tolerated the procedures well. Figure 12 demonstrates an intraoral view of the 
extraction to healing at 28 days. The images demonstrate size of the maxillary right first molar, 
the configuration and divergence of the five roots, the defect after the round bur was used to 
remove interradicular bone and residual roots, and the clinical evidence of the collapse of the 
alveolar ridge in the area of the missing tooth. 
I. µCT Linear Measurements  
 The results for the µCT linear measurements for the mid-buccal ridge width, buccal 
ridge height, mid-palatal ridge width, palatal ridge height, interproximal height of bone mesial to 
M2 adjacent to the extraction socket, and interproximal bone distal to M2 are summarized in 
Figures 13-16.  Differences in linear measurements demonstrated that extraction-associated 
bone loss was evident on buccal, palatal, and interproximal bone, and on palatal bone width 
both among the time points and from extraction to control side. Radiographic changes day 0 to 
28 are seen in Figure 17. The mid-buccal width demonstrated no significant differences, but 
there was extreme variability in the recorded values (Figures 18 and 19). The buccal height 
demonstrated statistically significant loss between 7 and 28 day extraction sites and statistically 
significant loss at 14 days between the extraction and control sites (Figure 14). The mid-palatal 
width demonstrated statistically significant losses between extraction sites at days 7 and 28, 14 
and 28, and 0 and 28 healing time periods, and statistically significant losses at the extraction 
compared to the control sites at 28 days (Figure 15). The palatal height demonstrated 
statistically significant losses at the extraction sites between days 0 and 28 and between the 
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extraction and control sites at 0 (slight difference), and more loss at 14 and 28 days (Figure 16). 
The progression of palatal bone loss was evident radiographically when evaluating 
representative sections at the time periods from 0 day to 28 days (Figure 17). The interproximal 
bone on the distal aspect of the socket, mesial to M2, demonstrated statistically significant bone 
loss on the extraction site between 0 and 28 days and between the extraction and control sites 
at 7, 14, and 28 days (Figure 18). As expected, there was no loss of interproximal bone on the 
distal aspect of M2 where the periodontal tissue was not manipulated (Figure 19). There were 
no differences in the control groups for parameters measured at the various time points (Figures 
18 and 19). The progression of bone loss was evident radiographically when evaluating the time 
periods from 0 day to 28 days (Figure 20). 
 Measurements were repeated in 10% of samples and results for the mixed model 
analysis of variance to determine intra-examiner variability by calculating the intra-class 
correlation revealed that there was good to excellent reproducibility with all values and are 
summarized in Tables 2 and 3. Overall, the variability between animals was much greater than 
variability within the same animal (observations by the examiner) based on the calculated 
values. The data reported from the extraction sites all had excellent reproducibility as the ICC 
was 0.978 or above with the exception of good reproducibility of the 1.25 mm buccal width with 
an ICC of 0.844 and the 1.25 mm palatal width with an ICC of 0.882. Due to the reproducibility of 
the buccal and palatal width at 1.25 mm from the reference point, those measurements were 
referenced for the width of the buccal and palatal alveolar bone.  
 II. µCT Volumetric Measurements  
 Means of volumetric measurements are summarized in Figures 21 and 22. The µCT 
volumetric measurements that produced statistically significant differences among various 
groups were mean bone mineral density (BMD) and bone surface density (BSD). Palatal ridge 
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BMD increased in both grafted sites compared to immediately post-extraction and after 28 days. 
BSD increased in the BMM+SIM ridge compared to no graft or BMM alone at 28 days. There 
were no differences in the control groups at the various time points.  
 III. Histological Analysis 
 The histological results of parameters for quantifying and qualifying the inflammatory 
response adjacent to the palatal alveolar crest are reported in Figures 23 and 24. Compared to 
the untreated control, day 7, day 14, and day 28 all demonstrated a statistically significant 
increase in infiltration density of inflammatory cells (Figure 23). The degree of inflammation 
demonstrated a statistically significant increase between the untreated control and day 7, day 
14, and day 28 measurements (Figure 24). The degree of inflammation was decreased in both 
grafting material groups. 
 Evaluating the palatal alveolar crest for cellular indicators of bone turnover, there were 
significant differences in the percentage of bone surface occupied by osteoblasts and 
osteoclasts (Figures 25 and 26). Compared to the untreated control, day 7, day 14, and day 28 all 
demonstrated a statistically significant increase in the percentage of osteoblasts at the bone 
surface and another statistically significant increase was present between 7 and 28 days. The 
percentage of osteoclasts at the bone surface also produced statistically significant increases 
between the untreated control and day 7, day 14, and day 28.  Both grafting materials 
demonstrated a decrease in the percentage of osteoclasts at 28 days compared to ungrafted 
sites.  
 IV. ELISA 
 There were no significant differences in the adjusted level of PGE2 in any of the time 
periods from Part 1 of the study (data not shown).  
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Part 2 
 For Part 2, the weight of the animals among groups (Table 4) was not different and no 
significant weight was lost in any group. No animals died prematurely during Part 2 of the study 
and all animals tolerated the procedures well. Figure 12 represents clinical views of the grafted 
sites from extraction to healing at 28 days.  
I. µCT Linear Measurements  
 The results for the µCT linear measurements for the Part 2 specimens’ mid-buccal ridge 
width, buccal ridge height, mid-palatal ridge width, palatal ridge height, loss of bone mesial to 
M2 adjacent to the extraction socket, interproximal bone distal to M2, total ridge width, and 
total ridge area are summarized in Figures 14, 16, 18, 19, 29 and 30. There was a statistically 
significant loss in palatal height between the extraction sites at day 0 and day 28 BMM, day 0 
and day 28 BMM+SIM, and extraction and control sites at both graft intervention groups BMM 
and BMM+SIM (Figure 16). The interproximal bone on the mesial aspect of M2 demonstrated 
statistically significant decreases between the day 28 untreated extraction group and the day 28 
BMM+SIM group and between the extraction and control groups for both day 28 BMM and day 
28 BMM+SIM groups (Figure 18). There was no statistically significant change in the height of 
the buccal alveolar bone or in the loss of interproximal bone on the distal aspect of M2, shown 
in Figure 14 and 18, respectively. The total width of the ridge showed statistically significant 
increases between the untreated day 28 and day 28 BMM and the untreated day 28 and day 28 
BMM+SIM groups, as well as between the day 28 BMM+SIM experimental and control groups 
(Figure 29). The final linear µCT measurement that demonstrated statistically significant 
differences was the recorded total ridge area where an increase was noted between the day 0 
and day 28 BMM+SIM, and untreated day 28 and day 28 BMM+SIM groups (Figure 30). The 
progression of buccal and palatal bone changes were evident radiographically when comparing 
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representative sections of the untreated day 28 group, the day 28 BMM group, and the day 28 
BMM+SIM group (Figure 31). Similarly, changes were also evident in the same groups when 
viewing the sagittal sections for interproximal bone changes (Figure 32). 
 II. µCT Volumetric Measurements 
The µCT volumetric measurements results that produced statistically significant 
differences among various groups were mean bone mineral density (BMD) and bone surface 
density (BSD), summarized in Figures 21 and 22. The statistically significant differences were 
noted as increases in mean BMD at the extraction sites between untreated day 0 and day 28 
BMM, untreated day 0 and day 28 BMM+SIM, untreated day 14 and day 28 BMM+SIM, 
untreated day 28 and day 28 BMM, and untreated day 28 and day 28 BMM+SIM (Figure 21). The 
BSD demonstrated statistically significant increases at the extraction sites between untreated 
day 28 and day 28 BMM+SIM and between day 28 BMM and day 28 BMM+SIM (Figure 22). 
There were no differences noted between the extraction and control sites for the Part 2 groups.  
 II. Histological Analysis 
 Evaluating the histologic results demonstrated statistically significant differences in 
parameters for inflammation and in bone surface cells present, summarized in Figures 23 and 
24. There was a statistically significant decrease in the inflammatory infiltrate density in the 
palatal alveolar crest adjacent to extraction sites between untreated day 28 and day 28 
BMM+SIM (Figure 23). The degree of inflammation showed statistically significantly decreases in 
the extraction sites between day 7 and day 28 BMM, day 14 and day 28 BMM+SIM, day 28 and 
day 28 BMM, day 14 and day 28 BMM+SIM, and day 28 and day 28 BMM+SIM (Figure 24).  
 Percentage of osteoblasts and osteoclasts on the bone surface of the palatal alveolar 
crest adjacent to the extraction sites differences are summarized in Figures 25 and 26. There 
was no statistically significant difference in the percentage of osteoblasts on the bone surface in 
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Part 2 (Figure 25); however, the percentage of osteoclasts on the bone surface showed a 
statistically significant decrease between untreated day 28 and day 28 BMM and between 
untreated day 28 and day 28 BMM+SIM (Figure 26). The measurement of quiescent bone 
surface produced a statistically significant increase between extraction groups of the untreated 
day 28 control and day 28 BMM and between untreated day 28 and day 28 BMM+SIM (Figure 
27).  
III. ELISA 
  The results for the levels of PGE2/albumin ratio are reported in Figure 33. There was a 
statistically significant difference noted between the PGE2/albumin levels at day 7 between the 
untreated and BMM+SIM group.  
Correlations  
 Evaluation of significant concurrent correlations, that is, the correlations between 
parameters evaluated in the same specimen at the same time point are summarized in Table 5. 
At day 7, there is a positive correlation between buccal height versus inflammatory infiltrate 
density (R = 0.74, p = 0.037), and degree of inflammation (R = 0.80, p = 0.016), and a negative 
correlation between BSD and percentage osteoblasts on the bone surface (R = -0.83, p = 0.01). 
There were no significant correlations at day 14. Contrary to day 7, the untreated day 28 group 
demonstrated a negative correlation for palatal height versus inflammatory infiltrate density (R 
= -0.78, p = 0.013) and percentage osteoclasts (R = -0.78, p = 0.013). For the day 28 BMM group, 
there was a positive correlation between mean BMD and percentage osteoclasts (R = 0.82, p = 
0.023) and a negative correlation between BSD and degree of inflammation (R = -0.78, p = 
0.034). Finally, for the day 28 BMM+SIM group, there was a positive correlation between total 
ridge width and percentage osteoblasts on the bone surface (R = 0.71, p = 0.047), and a positive 
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correlation between the 14 day PGE2 level and the percentage of osteoclasts on the bone 
surface (R = 0.77, p = 0.024).  
 It appears that increased inflammation is not harmful to bone when the inflammation 
occurs early (in the first 7 days). However, if the inflammation is persistent (14 days), the 
increased presence of inflammation and an increase in the number of bone surface osteoclasts 
is harmful to the volume and quality of bone at later stages of healing. When evaluating grafted 
sites, an elevated level of PGE2 early appears to be not harmful to bone area or turnover and is 
not a pro-inflammatory marker. Finally, the presence of SIM is associated with an increased 
number of bone surface osteoblasts and the amount of bone width.  
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TABLES  Table 1: Experimental Group 
Group n Day 0 Day 7 Day14 Day 28 
1 8 Right side: M1 defect 
Left side: control 
Euthanize 
 
   
2 8 Right side: M1 defect 
Left side: M1 control 
 
Euthanize   
3 8 Right side: M1 defect 
Left side: M1 control 
 
 Euthanize  
4 9 Right side: M1 defect 
Left side: M1 control 
 
Socket fluid Socket fluid Socket fluid 
Euthanize 
5 8 Right side: M1 defect + 
BMM graft 
Left side: M1 control 
 
Socket fluid Socket fluid Socket fluid 
Euthanize 
6 9 Right side: M1 defect + 
BMM+SIM graft 
Left side: M1 control 
 
Socket fluid Socket fluid Socket fluid 
Euthanize 
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Table 2: Agreements among Measurements from Coronal Images 
 Left transaxial (ICC, 95% CI) Right transaxial (ICC, 95% CI) 
Mid-Buccal width 0.844 (-0.094, 0.995) 0.978 (0.645, 0.999) 
Buccal Height 0.574 (-0.103, 0.983) 0.850 (-0.065, 0.996) 
Mid-Palatal width 0.979 (0.666, 0.999) 0.882 (-0.326, 0.997) 
Palatal Height 0.964 (0.522, 0.999) 0.829 (-0.105, 0.995) 
 
 
 
Table 3: Agreements among Measurements from Sagittal Images 
 Left Coronal (ICC, 95% CI) Right Coronal (ICC, 95% CI) 
Distal height 0.983 (0.660, 1.000) 0.997 (0.901, 1.000) 
Mesial height 0.993 (0.478, 1.000) 0.999 (0.988, 1.000) 
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Table 4: Animal Weight 
weight 
Day 0 group Day 7 group Day 14 group Day 28 group 
Day 28 BMM 
group 
Day 28 
BMM+SIM 
group 
 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Day 0 
299.0
0 11.93 337.13 26.74 338.00 19.49 310.56 22.63 312.88 20.46 306.56 25.06 
Day 7 
 
329.00 22.85 335.88 13.92 304.89 22.86 308.75 22.17 309.11 20.81 
Day 14 
 
333.75 14.36 308.11 24.92 314.50 17.91 313.78 19.78 
Day 28 
 312.33 21.98 314.63 16.09 307.00 20.13 
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Table 5: Significant Correlations 
group correlations  R value p value 
Day 7 
Infiltrate Density 
and 
Buccal Height 
0.74 0.037 
Degree of Inflammation 
and 
Buccal Height 
0.80 0.016 
BSD 
and  
Osteoblast/perimeter 
-0.83 0.01 
Day 14 none 
Day 28 
Infiltrate Density 
and 
Palatal Height 
-0.78 0.013 
Osteoclast/perimeter  
and 
Palatal Height 
-0.78 0.013 
Day 28 
BMM 
Degree of Inflammation 
and 
BSD 
-0.79 0.034 
Osteoclast/perimeter 
and  
Mean BMD 
0.82 0.023 
Day 28 
BMM+SIM 
Osteoblast/perimeter 
and  
Total Ridge Width 
0.71 0.047 
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FIGURES 
 
 
Figure 1: Image orientation for buccal and palatal measurements for Part 1 and 2. 
  
 
Figure 1: Image orientation for buccal and palatal measurements for Part 1 and 2. 
Example of the image in the computer used to orient the 3D images (DataViewer, Bruker microCT, 
Kontich, Belgium). Note the red, green, and blue orientation lines corresponding to the three planes. 
The image orientation was manipulated for a coronal slice to measure the buccal and palatal alveolar 
bone. The coronal section (lower left) was imported into a secondary software used to obtain 
measurements (CTAn, Bruker microCT, Kontich, Belgium). Top left: sagittal view, “transaxial section”. 
Bottom left: superior view, “coronal section”. Bottom right: coronal view, “sagittal section”. 
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A. 
Day 0
 
B. 
Day 0
 
Figure 2: Buccal and palatal measurements for Part 1 and 2. 
Figure 2: Buccal and palatal measurements for Part 1 and 2. 
Example of the image in the software used to obtain measurements (CTAn, Bruker microCT, Kontich, 
Belgium) for buccal and palatal height and width. A. The height and width of the buccal cortical plate 
was measured from the superior and lateral aspect and advancing in 0.25 mm increments to the 
alveolar crest and then measuring the perpendicular width. The height and width of the palatal bone 
was measured from the most superior and mesial aspect that corresponded to the alveolar process of 
the maxilla. B. To measure total width, the mid-socket slice was used and the measurement was 
obtained by identifying the perpendicular line of greatest width buccal to palatal to the point 1.25 mm 
crestal from the most superior and lateral point of the buccal cortical plate.  
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Figure 3: Image orientation for interproximal measurements for Part 1 and 2. 
Figure 3: Image orientation for interproximal measurements for Part 1 and 2. 
Example of the image in the computer used to orient the 3D images (DataViewer, Bruker microCT, 
Kontich, Belgium). Note the red, green, and blue orientation lines corresponding to the three planes. 
The image orientation was manipulated for a sagittal slice to measure the interproximal alveolar bone 
mesial and distal to M2. The coronal section (lower left) was imported into a secondary software used 
to obtain measurements (CTAn, Bruker microCT, Kontich, Belgium). Top left: sagittal view, “sagittal 
section”. Bottom left: superior view, “coronal section”. Bottom right: coronal view, “transaxial 
section”.  
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Figure 4: Interproximal measurements for Part 1 and 2. 
Figure 4: interproximal measurements for Part 1 and 2. 
Representative 7 day specimen. Example of the image in the software used to obtain measurements 
(CTAn, Bruker microCT, Kontich, Belgium) for buccal and palatal height and width. The amount of 
interproximal bone loss was measured by tracing a line from the CEJ to the ABC parallel to the root 
structure and recording the linear distance until the most crestal portion of alveolar bone present. 
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Figure 5: Interproximal measurements for Part 1 and Part 2. 
Representative 28 day specimen. Example of the image in the software used to obtain measurements 
(CTAn, Bruker microCT, Kontich, Belgium) for interproximal bone height. The amount of interproximal 
bone loss was measured by tracing a line from the CEJ to the ABC parallel to the root structure and 
recording the linear distance until the most crestal portion of alveolar bone present. 
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Figure 6: Volumetric measurements for Part 1 and Part 2. 
Orientation of the image and definition of the ROI to determine volumetric and density values of bone 
quality. The ROI was confined to the palatal crest area using an orientation of the most cervical and 
with the closest approximation to the socket that a standard rectangular box (0.261 x 0.450 x 0.340 
µm) could be placed. 
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A.  
B.  
C.  
D.  
Figure 7: H&E Section for Part 1 and Part 2 inflammation grading. Low magnification. 
Representative sections for the qualitative assessment of the relative degree of inflammation using a 
scale modified from Kristensen et al. (2008). The inflammation as rated 0 to 3. A. 0 = no inflammation, 
no inflammatory cells present, control/left side. B. 1 = mild inflammation, few, scattered inflammatory 
cells present. C. 2 = moderate inflammation, multiple clearly present inflammatory cells present. D. 3 
= severe inflammation, massive presence of inflammatory cells. Note: this specimen was graded as 
moderate with focally severe inflammation. PAB = palatal alveolar bone. EPI = epithelium. ES = 
extraction socket base. T = tooth. 
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A.   B.  
C.  D.  
E.  F.   
Figure 8: H&E Section for Part 1 and Part 2 inflammation staging. Low magnification. 
Representative sections for the qualitative assessment of the predominant inflammatory cell type 
present and a qualitative assessment regarding the stage of inflammation as also made in the same 
manner and scored as either acute, mixed acute and chronic, or chronic, based on the predominant 
cell types present The box represents the area of interest and the area of higher magnification. A. 
Acute inflammation characterized by neutrophilic infiltrate. B. Higher magnification of acute 
inflammation. C. Mixed acute and chronic inflammation with neutrophilic and lymphocytic infiltrate. 
D. Higher magnification of mixed acute and chronic inflammation.  E. Chronic inflammation 
characterized by a predominantly lymphocytic infiltrate. F. Higher magnification of chronic 
inflammation. PAB = palatal alveolar bone. EPI = epithelium. ES = extraction socket base.  
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A.   
B.  
Figure 9: H&E Section for Part 1 and Part 2 inflammatory infiltrate. Low magnification. 
Roughly 600,000 µm of connective tissue near the palatal crestal bone area was outlined and the area 
of inflammatory infiltrate contained within the outer perimeter was recorded. A. Raw image. B. Image 
with the traced total area of interest and the area of inflammation outlined. PAB = palatal alveolar 
bone. EPI = epithelium. ES = extraction socket base.  
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A.  
B.   
C.  
Figure 10: H&E for surface cells. High magnification. 
Representative sections demonstrating the osteoblasts and osteoclasts on the bone surface. A. 
Osteoblasts (OB). Note: contain one nucleus and are found in a plump single layer on the surface of 
the bone. B. Osteoclasts (OC). Note:  multinuclear appearance and their presence on the surface of 
accompanied by their resorptive area or Howship’s lacunae. C. Quiescent surface (Q). Defined as 
surface not occupied by an active osteoblast or osteoclast.  
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A.   
B.  
Figure 11: H&E Section for Part 1 and Part 2 bone surface cells. High magnification. 
Roughly 4000 µm of palatal crestal bone surface perimeter was outlined and the cumulative perimeter 
of bone surface area lined by osteoblasts and osteoclasts was recorded and non-osteoblast or 
osteoclast perimeter (by subtraction of osteoblast and osteoclast perimeter from the total perimeter) 
was described as quiescent. A. Raw image. B. Image with the total perimeter of bone surface of 
interest traced and the regions corresponding to osteoblasts and osteoclasts lining the perimeter. PAB 
= palatal alveolar bone. NB = neurovascular bundle on palatal aspect. ES = extraction socket.  
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    A.     B.                      
C.      D.  
E.       
Figure 12: Part 1 Extraction and Healing. 
A. Extracted right maxillary first molar with a Marquis color-code probe with 3mm calibrations for size 
comparison. B. Apical view of extracted right maxillary first molar to demonstrate presence and 
divergence of the 5 roots. C. View of the right maxillary molar extraction site and defect. D. The 
extraction site sealed with cyanoacrylate adhesive (PeriAcryl 90, GluStitch Inc, Delta, BC, Canada). E. 
Extraction site after 28 days of healing. Note the evidence of a reduction in the height and width of 
the alveolar ridge surrounding the socket.  
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Figure 13: Part 1 Mid-Buccal Width. 
Group comparisons and experimental and control for linear measurement of buccal width (mean ± 
standard deviation). No statistical differences found. 
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Figure 14: Buccal Height for Parts 1 and 2. 
Group comparisons and experimental and control for linear measurement of buccal height (mean ± 
standard deviation). Statistical differences noted. 
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Figure 15: Part 1 Mid-Palatal Width. 
Group comparisons and experimental and control for linear measurement of palatal width (mean ± 
standard deviation). Statistical differences noted. 
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Figure 16: Palatal Height for Parts 1 and 2. 
Group comparisons and experimental and control for linear measurement of palatal height (mean ± 
standard deviation). Statistical differences noted. 
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A.   
B.  
C.  
D.  
Figure 17: Representative µCT for buccal and palatal bone loss from Part 1. 
A. Day 0. B. Day 7. C. Day 14. D. Day 28. 
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Figure 18: Loss of interproximal bone mesial to M2 for Parts 1 and 2. 
Group comparisons and experimental and control for linear measurement of loss of interproximal 
bone on the mesial aspect of M2, or distal to the extraction socket (mean ± standard deviation). 
Statistical differences noted. 
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Figure 19: Loss of interproximal bone distal to M2 for Parts 1 and 2. 
Group comparisons and experimental and control for linear measurement of loss of interproximal 
bone on the distal aspect of M2 (mean ± standard deviation). Statistical differences noted. 
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Figure 13: Loss of interproximal bone distal to M2 for Part 1. Group comparisons and 
experimental and control for linear measurement of loss of interproximal bone on the distal 
aspect of M2 (mean ± standard deviation). Statistical differences noted. 
 
 
 
 
A.  
B.  
C.  
D.  
Figure 20: Representative µCT for interproximal bone loss from Part 1. 
A. Day 0. B. Day 7. C. Day 14. D. Day 28. 
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Figure 21: Bone Mineral Density. 
Group comparisons and experimental and control for volumetric measurement of mean bone mineral 
density (mean ± standard deviation). Statistical differences noted. 
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Figure 22: Bone Surface Density. 
Group comparisons and experimental and control for volumetric measurement of bone surface 
density calculated as bone surface (BS)/ trabecular volume (TV) (mean ± standard deviation). 
Statistical differences noted. 
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Figure 23: Inflammatory Infiltrate Density. 
Group comparisons and experimental and control for histologic measurement of inflammatory 
infiltrate density (mean ± standard deviation). Statistical differences noted. 
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Figure 24: Degree of Inflammation.  
Group comparisons and experimental and untreated control for histologic measurement of degree of 
inflammation (mean ± standard deviation). Statistical differences noted. 
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Figure 25: Percentage of Osteoblasts on Bone Surface. 
Group comparisons and experimental and untreated control for histologic measurement of 
percentage of osteoblasts on bone surface (mean ± standard deviation). Statistical differences noted. 
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Figure 26: Percentage of Osteoclasts on Bone Surface. 
Group comparisons and experimental and untreated control for histologic measurement of 
percentage of osteoclasts on bone surface (mean ± standard deviation). Statistical differences noted. 
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Figure 27: Bone Surface Quiescence. 
Group comparisons and experimental and untreated control for histologic measurement of bone 
surface quiescence (mean ± standard error). Statistical differences noted.  
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    A.     B.                      
C.     D.  
E.      F.  
Figure 28: Part 2 Extraction and Healing. 
A. Extracted right maxillary first molar with a Marquis color-code probe with 3mm calibrations for size 
comparison. B. Apical view of extracted right maxillary first molar to demonstrate presence and 
divergence of the 5 roots. C. View of the right maxillary molar extraction. D. Site grafted with BMM + 
SIM with 0.01 g of graft material placed in the defect. E. The extraction site and graft material sealed 
with cyanoacrylate adhesive (PeriAcryl 90, GluStitch Inc, Delta, BC, Canada). F. The healed, grafted site 
at 28 days.  
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Figure 29: Total Ridge Width. 
Group comparisons and experimental and untreated control for µCT linear measurement of total 
alveolar ridge width (mean ± standard deviation). Statistical differences noted. 
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Figure 30: Total Ridge Area. 
Group comparisons and experimental and untreated control for µCT measurement of total alveolar 
ridge area (mean ± standard deviation). Statistical differences noted. 
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A.   
B.  
C.  
Figure 31: Representative µCT for buccal and palatal bone changes from Part 2. 
A. Day 28. B. Day 28 BMM. C. Day 28 BMM+SIM. 
70 
 
 
A.  
B.  
C.  
Figure 32: Representative µCT for interproximal bone changes from Part 2. 
A. Day 28. B. Day 28 BMM. C. Day 28 BMM+SIM. 
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Figure 33: PGE2/Albumin Ratio from 28 Day Groups. 
Group comparisons for all day 28 groups for socket fluid samples at day 7 for ELISA measurement of 
PGE2/Albumin Ratio (mean ± standard error). Statistical differences noted. 
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DISCUSSION 
Many fields of dentistry are interested in the preservation of alveolar bone following 
extraction due to the well-documented changes in bone quality and quantity at the site (Van der 
Weijden et al. 2009; Sun et al. 2013; Sadeghi et al. 2016) and several techniques and 
interventions have been proposed to reduce the negative effects of post-extraction 
conformational changes (Darby et al. 2008; Pagni et al. 2012). Recent studies utilizing µCT in rat 
extraction studies (Jin et al. 2004; Park et al. 2007) have simply sought to validate the 
methodology, in contrast to the current study that sought to characterize bone loss 
measurements against which to compare various interventions and pharmacomanipulations of 
the extraction sites. The current study was initiated to, first, characterize inflammation and bone 
loss at the alveolar ridge following extraction in a standardized, cost-effective, rat model, and 
second, to evaluate possible interventions. In the current study, the unmanipulated physiologic 
bone quantity and quality changes were quantified to explore the impact of inflammation on 
the healing process. A proof-of-principle study also was conducted of a grafted socket with or 
without locally-released simvastatin. Changes were evident in the various dimensions of the 
alveolar bone in these rats after the 28-day period for both Part 1 and Part 2 of the study. Bone 
loss was evaluated between groups for linear and volumetric changes by micro computed-
tomography (µCT) and the process of inflammation was monitored by histologic and PGE2 
analysis for Parts 1 and 2.  
Differences in weight are a valuable method for determining if there is an overall effect 
on the metabolism and survivability of the animal after treatment with a drug. In Part 1 and Part 
2, no animals died and all animals maintained their weight and no statistically significant 
differences were noted. Overall, there were no changes evident across the time periods in the 
28 day groups, demonstrating that there was no adverse reaction to the surgery or the sedation 
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methods relative to food intake and diet throughout the study. Previous studies of extractions in 
rats did not report any negative lasting effect of the extractions on the survivability and ability of 
the animals to thrive (Bodner et al. 1993; Wu et al. 2008).   
Historical and more recent studies alike have evaluated the histologic changes and 
stages of the healing extraction socket in rats (Pietrokovski & Massler 1967; Todo 1968; Kim et 
al. 2012). The periosteal aspect of the alveolar ridge demonstrated bone turnover and 
osteoblastic activity in the current study in the same way studies by Pietrokovski & Massler 
(1967) and Todo (1968) found in previous studies. A study by Kim et al. (2012) identified that 
normal healing, even in rats, progresses in distinctive phases, consistent with the phases of 
healing progressing through the inflammatory processes also identified in the current study. The 
Kim et al. (2012) study evaluated the inflammatory infiltrate and bone surface cells at the 
periphery of the healing wound and determined that after a rapid acute inflammatory response, 
that response was noted to diminish at about 10 days when indications of bone turnover and 
evidence of new bone were coincidently evident. These findings are consistent with the findings 
from Part 1 where the inflammatory infiltrate density and degree of inflammation decreased to 
a statistically significant degree between day 7 and day 28. Just as Kim et al. (2012) found bone 
cells at the surface that indicate bone turnover (osteoblasts and osteoclasts), the current study 
found that osteoblasts increased between day 7 and day 28 (Figure 25).  
In a recent study by Giorgetti et al. (2012) male mature rats subjected to mandibular 
molar extraction were monitored at distinct time points for histologic evidence of bone changes. 
Giorgetti et al. (2012) concluded that new bone formation was evident at the later time points, 
7 and 14 days after extraction. The study by Giorgetti et al. (2012) used a histometric method 
for measuring bone morphologic changes that was different than the current study’s methods 
and it evaluated the fundus of the socket. Since loss of alveolar crest height and width is a 
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critical event post-extraction, often limiting available bone for future implants or prosthesis 
(Seibert & Salama 1996; Tomlin et al. 2014), study of the alveolar crest is important. 
Pietrokovski & Massler (1967) have previously examined the periosteal region of the 
healing socket and, like the focus of this study, evaluated the region of the alveolar crest for 
evidence of bone turnover. They found that there was a collapse of the alveolar ridge over the 
time periods evaluated (1 week, 2 weeks, 4 weeks, 8 weeks) and there was evidence of bone 
turnover with osteoblastic activity on the palatal aspect of the socket, consistent with the 
current study’s findings. The current study focused on the palatal aspect with the histologic and 
µCT findings because the palatal ridge was less affected by the extraction procedure than the 
thin buccal plate which was more likely to be disrupted or fractured. However, when comparing 
day 0 to controls, it appeared that the simple procedure of extraction resulted in changes in the 
alveolar bone, either by direct damage by trauma or fracture of alveolar bone or indirect effect 
from the heat of the rotary instrument (Figure 16). In the current study, it was identified that 
although some changes were evident at the earlier time points of 7 and 14 days, there were 
more dramatic changes evident after 28 days for buccal bone height (Figure 14), palatal bone 
height (Figure 16), interproximal bone height (Figure 18), and total ridge width (Figure 29), 
corresponding to other studies that demonstrated the effectiveness of using a 28-day study 
time frame to evaluate alveolar bone changes following interventions (Bodner et al. 1993; 
Schropp et al. 2003; Wu et al. 2008). The cells on the bone surface became increasingly active 
towards an appositional process by osteoblastic activity at days 14 and 28 (Figure 25).  
A study by Shimizu et al. (1998) evaluated maxillary molar extraction sites by scanning 
electron microscopy (SEM) and light microscopic analysis and found that there were areas of 
bone resorption on the buccal and palatal aspects of the extraction site. Consistent with the 
current study’s findings that significant loss of palatal bone height and width occurs (Figure 15 
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and 16), Shimizu et al. (1998) identified there were more significant areas of resorption on the 
palatal aspect of the extraction socket. The current study additionally looked at the 
interproximal bone and found that there is a significant reduction in the alveolar bone height on 
the distal aspect of the extraction socket, adjacent to M2 (Figure 18). Human studies have 
substantiated this finding of interproximal bone loss, but no studies in rats have previously 
quantified the amount of interproximal bone loss. Compared to human studies of healing 
extraction sockets (Araujo & Lindhe 2005; Avila-Ortiz et al. 2014; Sadeghi et al. 2016), the overall 
pattern of healing was consistent between those studies and the current study in the rat model 
by µCT and histologic analysis. In humans, Araujo and Lindhe (2005) identified significant loss of 
the buccal alveolar bone height and although there is reduction of palatal alveolar bone height, 
it was not found to be statistically significant. In the current study there was significant loss of 
both buccal and palatal alveolar height (Figures 14 and 16). 
The results from Part 1 concluded that 7 days after extraction, there is a strong acute 
inflammatory reaction that does not correlate to a measurable loss of buccal bone height (Table 
5). Contrary to the findings by Giorgetti et al. (2012), the 14-day period did not demonstrate any 
significant histologic changes that corresponded to bony contour changes. In the current study 
evaluating the healing from day 7 to day 28, the inflammatory reaction decreased while the 
bone loss increased over the same time period (Figures 14, 16, 18, 23, 24 and 29), but 
inflammation remaining at day 28 was negatively correlated to palatal bone height.  
Part 2 of the current study focused on the effect of bone product grafting following 
extractions both with and without the addition of simvastatin. Grafting has been shown to 
reduce the loss of alveolar bone height and width in humans (Avila-Ortiz et al. 2014; Sadeghi et 
al. 2016), and the same results were found in the current study where grafting significantly 
reduced the loss of interproximal alveolar bone, total ridge area, and total ridge width (Figures 
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18, 29 and 30). Based on a thorough literature review, grafting extraction sockets with 
simvastatin in rats has not been previously studied and, thus, comparisons can only be made 
with previous applications of local simvastatin administration.  As simvastatin has proven 
anabolic in previous applications (Mundy et al. 1999), and rodent studies have demonstrated 
bone anabolic (Thylin et al. 2002; Stein et al. 2005; Lee et al. 2011) and anti-inflammatory (Funk 
et al. 2008; George et al. 2013) abilities, this current study sought to identify any differences in 
bone quality or quantity following extraction that may result from local administration. The 
doses of simvastatin administered in previous studies (Stein et al. 2005; Lee et al. 2011; George 
et al. 2013) were much higher (0.5 to 2 mg) than the doses in the graft of the current study 
(approximately 0.2 mg). This is due to underestimation of the amount of previously prepared 
BMM+SIM graft material that could be placed in the standardized extraction defect. Even so, an 
effect was noted for BMM+SIM in increasing bone surface density, decreasing inflammatory 
infiltrate, and increasing ridge area. Future research with the extraction model in rats will need 
to test higher doses to be comparable to other studies.  
With the grafted extraction sites evaluated at 28 days, there were no previous studies 
against which to compare the results of the current study, but the findings were that there was 
significantly less bone loss on the mesial aspect of M2 after 28 days when comparing no 
intervention to the BMM+SIM group (Figure 18). In the BMM+SIM group, there was less 
inflammation as measured by the total inflammatory infiltrate density than the untreated 
socket, but not the BMM alone socket (Figure 23) and a lower degree of inflammation in both 
grafted groups (Figure 24). Additionally, BMM+SIM resulted in more BSD than BMM alone 
(Figure 22), but both grafted sockets had increased BMD compared to ungrafted sites (Figure 
21). Compared to non-interventions, the graft demonstrated an ability to preserve the ridge 
width, ridge area, and interproximal ridge height bone lost by extraction, but did not result in 
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total preservation or regeneration (Figure 16). However, both BMM and BMM+SIM preserved 
total ridge width, and only BMM+SIM enhanced total ridge width and total area as compared to 
controls (Figures 28 and 29).  
The current study identified that day 7 infiltrate density and degree of inflammation 
were positively correlated with buccal bone height (Table 5). An apparent unexpected finding at 
day 7 of Part 1 of the study was the negative correlation between BSD and percentage 
osteoblasts (Table 5). However, perhaps this is explained by the phenomenon that osteoblasts 
first lay down an unmineralized secretory product, osteoid, in the apposition of new bone, thus 
that layer was likely recorded with low BMD by the µCT software. This finding from the current 
study is consistent with the findings of Bodner et al. (1993) who identified bone formation 
occurring at 7 and 14 days of healing and bone maturation at 28 days. Differences that can be 
identified between the work by Bodner et al. (1993) and the current study included the new 
applications for µCT that the current study utilized, but the histologic methods were consistent. 
In the untreated day 28 specimens, there was a negative correlation between infiltrate 
density and palatal height, and in the 28 day BMM group, there was a negative correlation 
between degree of inflammation and BSD (Table 5), suggesting that inflammation late in the 
healing cycle was harmful to bone quality as persistent and uncontrolled inflammation is 
damaging (Beltran et al. 2015). There was an expected negative correlation between infiltration 
density and palatal height in the untreated 28 day specimens, but an unexpected positive 
correlation between mean BMD and percentage of osteoclasts. If percent of osteoclasts is 
considered a marker of bone turnover, less turnover may lead to more bone density. BMM+SIM 
was associated with a positive correlation between percentage of osteoblasts and total ridge 
width. 
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 In assessing the role of PGE2, a previous study by Lee et al. (2011) showed that higher 
levels of PGE2 in the first week of healing enhanced bone growth. In the current study, day 7 
PGE2/Alb levels were significantly higher in BMM+SIM than the untreated sockets (Figure 33). 
Further studies must be conducted, but the current study supports the premise that high levels 
of PGE2/albumin during the first week may promote bone turnover in an anabolic manner, but 
after that first week, elevated PGE2 and inflammation may have a less desirable effects on 
alveolar bone.  
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CONCLUSIONS 
The following conclusions can be made from the results obtained in this study: 
1. The principal locations for bone loss following extraction in the current rat model 
without intervention were on the palatal and interproximal aspects of the site. 
2. This model shows promise for testing bone regeneration compounds to prevent 
crestal bone loss. 
3. Higher levels of PGE2 and a more intense inflammatory reaction early in healing are 
correlated with more bone quality and quantity. 
4. Grafting of the extraction sites demonstrated a reduction in the alveolar bone loss 
evident after 28 days of healing and BMM+SIM decreased inflammation and 
enhanced total alveolar ridge width. 
The hypothesis of this study was that increased peri-socket inflammation will cause 
decreased regeneration of bone height and width was not proven. The hypothesis that 
interventions after extraction, specifically grafting of the defect, will reduce the amount of bone 
loss was supported.   
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APPENDIX Part 1: Linear Measurements, Coronal Section, Control Side 
Specimen Group 
Buccal 
height 
Palatal 
height 
At 1.25 
Buccal 
Width 
At 1.25 
Palatal 
width 
Total ridge 
width 
A 8 2.525 2.151 0.000 0.728 3.356 
AA 8 2.534 2.351 0.461 0.933 3.092 
AB 6 2.736 2.174 0.000 0.96 
 
AC 4 2.552 1.926 0.666 0.776 
AD 2 2.178 1.785 0.542 0.682 
AE 8 2.324 1.783 0.721 0.697 3.23 
AF 6 2.527 1.943 0.668 0.639 
 
AG 4 2.665 1.946 0.802 0.566 
AH 2 2.166 1.893 0.525 0.733 
AI 8 2.145 1.915 0.470 0.478 3.092 
B 6 2.62 2.014 0.528 0.773 
 
C 4 2.588 1.94 0.566 0.702 
E 2 2.489 2.092 0.595 0.805 
F 8 2.284 1.838 0.524 0.442 2.957 
G 6 2.469 2.202 0.716 0.767 
 
H 4 2.555 2.076 0.598 0.659 
J 2 2.657 1.946 0.552 0.772 
K 8 1.858 1.51 0.611 0.5 2.745 
L 6 2.716 1.897 0.620 0.606 
 
M 4 2.517 1.872 1.246 0.662 
N 2 2.194 2.005 0.567 0.836 
O 8 2.405 1.858 0.539 0.741 3.285 
P 6 2.688 2.1 0.635 0.653 
 
Q 4 2.719 1.952 0.683 0.707 
R 2 2.528 2.112 0.597 0.74 
S 8 2.583 2.067 0.666 0.922 3.446 
T 6 2.382 2.098 0.606 0.77 
 
U 4 2.602 1.905 0.721 0.565 
V 2 2.387 1.893 0.422 0.5 
W 8 2.574 2.166 0.641 0.595 3.252 
X 6 2.359 2.037 0.450 0.756 
 
Y 4 2.762 2.628 0.606 1.028 
Z 2 2.469 1.836 0.744 0.795 
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Part 1: Linear Measurements, Sagittal Section, Control Side 
specimen group 
CEJ to ABC 
distal to m2 mesial to m2 
A 8 0.523 0.288 
AA 8 0.527 0.54 
AB 6 0.612 0.556 
AC 4 0.379 0.338 
AD 2 0.319 0.289 
AE 8 0.283 0.448 
AF 6 0.393 0.313 
AG 4 0.48 0.547 
AH 2 0.447 0.296 
AI 8 0.45 0.441 
B 6 0.442 0.423 
C 4 0.308 0.381 
E 2 0.32 0.339 
F 8 0.614 0.296 
G 6 0.421 0.418 
H 4 0.569 0.372 
J 2 0.262 0.587 
K 8 0.379 0.427 
L 6 0.487 2.165 
M 4 0.381 0.331 
N 2 0.289 0.254 
O 8 0.515 0.465 
P 6 0.628 0.386 
Q 4 0.508 0.483 
R 2 0.337 0.364 
S 8 0.205 0.243 
T 6 0.465 0.353 
U 4 0.639 0.553 
V 2 0.454 0.387 
W 8 0.479 0.553 
X 6 0.887 0.214 
Y 4 0.321 0.353 
Z 2 1.036 0.523 
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Part 1: Volumetric Measurements, Coronal Section, Control Side 
specimen group 
area mean 
BMD BV/TV BS/TV total buccal palatal 
A 8 7.84 3.383 3.869 1.11671 65.7891 41.38127 
AA 8 6.613 2.705 4.028 1.17527 57.72435 35.54262 
AB 6 7.92 3.477 4.483 1.08628 43.08351 35.39414 
AC 4 7.049 3.424 3.346 1.08695 93.25035 21.1727 
AD 2 6.228 2.784 3.581 1.13969 51.85294 41.2296 
AE 8 6.306 3.23 3.034 1.22079 20.6322 26.32053 
AF 6 6.937 3.627 3.687 1.17235 76.7359 31.620 
AG 4 7.117 3.777 3.675 1.19818 58.35974 37.52249 
AH 2 6.069 2.863 3.338 1.09317 53.07115 44.45661 
AI 8 6.406 2.888 3.804 1.15283 94.02531 22.03968 
B 6 6.786 3.405 3.543 1.22474 53.09267 39.52559 
C 4 7.118 3.578 3.734 1.20892 53.89536 43.01934 
E 2 7.343 3.289 3.863 1.09949 57.74211 39.0343 
F 8 5.738 2.798 3.594 1.14042 77.86151 33.80791 
G 6 6.958 3.529 3.471 1.19407 31.4720 35.36546 
H 4 7.313 3.237 3.917 1.12855 77.9356 28.81457 
J 2 7.167 3.087 3.861 1.18304 59.04615 41.87589 
K 8 4.372 2.37 1.913 1.14587 56.3327 42.05986 
L 6 7.437 3.523 3.753 1.13683 84.69045 30.03729 
M 4 4.297 2.529 1.841 1.14886 76.61471 34.52171 
N 2 6.35 2.72 3.408 1.13917 43.9010 42.59031 
O 8 6.502 2.955 3.473 1.1476 79.38857 28.66463 
P 6 7.296 3.537 3.648 1.20868 72.49805 36.31784 
Q 4 7.767 3.882 3.848 1.11996 91.94018 24.07935 
R 2 6.835 3.373 3.518 1.08157 65.64642 41.56635 
S 8 7.109 3.213 4.055 1.16158 61.67461 35.33547 
T 6 6.849 2.917 4.013 1.18700 74.25245 35.51578 
U 4 7.451 3.561 3.772 1.15947 61.69712 40.43564 
V 2 6.615 3.224 3.706 1.18082 45.96094 39.57756 
W 8 7.307 3.935 3.648 1.22018 46.98005 38.16429 
X 6 6.492 2.778 3.835 1.22799 51.52551 39.09945 
Y 4 8.506 3.684 4.709 1.13631 42.44360 40.54568 
Z 2 6.805 3.318 3.491 1.07431 50.37372 44.33213 
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Part 1: Linear Measurements, Coronal Section, Experimental Side 
specimen group 
Buccal 
height 
Palatal 
height 
At 1.25 
Buccal 
Width 
At 1.25 
Palatal 
Width 
Total 
ridge 
width 
A 7 0.958 1.082 0 0 0.16 
AA 7 2.146 1.075 1.594 0 1.867 
AB 5 2.292 1.42 0.851 0.72 
 
AC 3 2.056 2.358 0.306 0 
AD 1 1.379 1.803 0.074 0.629 
AE 7 2.053 1.542 0.494 0.45 0.857 
AF 5 2.109 1.34 0.471 0.543 
 
AG 3 2.715 1.948 0.61 0.789 
AH 1 2.056 1.744 0.505 0.666 
AI 7 2.149 0.919 0.828 0 0.828 
B 5 2.337 1.626 0.581 0.491 
 
C 3 2.651 2.08 0.848 0.63 
E 1 2.366 2.039 0.702 0.713 
F 7 1.031 1.961 0 0.454 0.639 
G 5 2.47 1.515 0.787 0.635 
 
H 3 2.224 1.943 0.649 0.655 
J 1 2.55 1.868 0.436 0.762 
K 7 1.741 1.384 0.772 0.392 0.762 
L 5 2.203 1.433 0.305 0.397 
 
M 3 2.332 1.917 0.625 0.937 
N 1 2.274 1.837 0.624 0.78 
O 7 2.164 1.249 1.401 0 2.118 
P 5 2.726 1.84 0.418 0.915 
 
Q 3 2.628 2.134 0.456 0.764 
R 1 2.343 1.932 0.831 0.519 
S 7 1.559 1.153 0.305 0 0.369 
T 5 2.402 1.618 0.339 0.713 
 
U 3 2.634 2.462 1.011 0.552 
V 1 1.917 1.922 0.106 0.451 
W 7 2.035 1.373 0.916 0.364 0.699 
X 5 1.807 1.538 0.189 0.523 
 
Y 3 1.772 2.289 0.117 0.702 
Z 1 2.738 1.662 1.027 0.4 
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Part 1: Linear Measurements, Sagittal Section, Experimental Side 
specimen group 
CEJ to AC 
distal to m2 mesial to m2 
A 7 0.368 2.375 
AA 7 0.491 1.812 
AB 5 0.755 0.544 
AC 3 0.421 0.504 
AD 1 0.249 0.526 
AE 7 0.262 1.912 
AF 5 0.494 1.916 
AG 3 0.32 0.688 
AH 1 0.537 0.456 
AI 7 0.697 2.438 
B 5 0.521 1.87 
C 3 0.425 0.359 
E 1 0.537 0.396 
F 7 0.814 1.151 
G 5 0.29 1.637 
H 3 0.653 0.5 
J 1 0.476 0.508 
K 7 0.396 2.451 
L 5 1.224 0.524 
M 3 0.37 0.353 
N 1 0.359 1.367 
O 7 0.37 1.889 
P 5 0.828 1.461 
Q 3 0.654 0.65 
R 1 0.326 0.552 
S 7 0.473 1.551 
T 5 0.408 1.783 
U 3 0.741 0.568 
V 1 0.279 0.343 
W 7 0.494 2.1841 
X 5 0.669 2.13 
Y 3 0.391 0.332 
Z 1 0.494 0.349 
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Part 1: Volumetric Measurements, Coronal Section, Experimental Side 
specimen group 
area 
mean BMD BV/TV BS/TV total buccal palatal 
A 7 2.556 1.81 0.597 1.33434 68.45437 36.21995 
AA 7 5.133 4.19 0.996 1.26473 75.74670 32.94163 
AB 5 5.215 2.495 2.516 1.31239 70.16788 35.63164 
AC 3 3.695 1.104 2.78 1.47243 29.76055 27.01848 
AD 1 3.255 1.315 1.938 1.39417 54.59972 38.56248 
AE 7 3.723 1.842 2.233 1.34674 58.60679 36.95086 
AF 5 2.237 0.861 1.54 1.35034 97.28516 21.22989 
AG 3 4.491 1.906 2.56 1.32309 95.55072 25.3470 
AH 1 3.612 1.713 1.821 1.27179 71.97186 40.89362 
AI 7 3.015 1.716 1.48 1.24302 64.50633 39.16527 
B 5 3.705 1.886 2.02 1.17187 91.19432 20.54619 
C 3 4.833 2.57 2.01 1.42778 49.43133 33.68933 
E 1 5.121 2.419 2.886 1.16602 79.04828 35.20235 
F 7 2.302 1.545 0.736 1.36653 49.11255 29.6530 
G 5 4.581 1.928 2.703 1.46287 51.10664 41.46869 
H 3 4.685 1.802 2.706 1.31222 74.60048 26.77056 
J 1 3.213 1.291 2.061 1.25151 39.72706 43.14048 
K 7 3.451 1.702 1.763 1.40183 50.37701 38.09159 
L 5 2.752 0.647 2.006 1.42190 97.97055 17.30113 
M 3 3.804 1.652 2.089 1.36674 55.64728 41.81488 
N 1 4.262 1.676 2.512 1.31857 65.95352 38.45656 
O 7 4.692 2.428 2.162 1.21818 94.57144 20.55683 
P 5 3.968 1.417 2.35 1.37582 93.55088 22.27349 
Q 3 3.873 1.713 2.19 1.4138 41.65096 37.56404 
R 1 4.446 1.943 2.452 1.27542 32.62973 35.75925 
S 7 2.176 1.371 0.671 1.31893 63.19286 33.66956 
T 5 3.122 0.961 2.111 1.43727 66.37437 39.82204 
U 3 3.594 1.512 1.8 1.32482 46.30391 35.79151 
V 1 2.646 1.859 0.617 1.36152 50.77540 44.07769 
W 7 4.017 1.999 1.947 1.37811 52.65591 38.59748 
X 5 1.948 0.7 1.313 1.51326 65.20213 37.6842 
Y 3 4.142 1.324 2.678 1.34044 66.60489 40.41352 
Z 1 4.617 2.772 2.114 1.36920 61.62941 43.73693 
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Part 1: Weight Measurements 
specimen group 
weight (g) 
0 day 7 day 14 day 28 day 
A 7 324 314 320 336 
AA 7 337 338 344 344 
AB 5 329 329 325 
 
AC 3 310 311 
 AD 1 276  
AE 7 283 279 281 282 
AF 5 338 322 319 
 
AG 3 342 323 
 AH 1 288  
AI 7 311 298 300 307 
B 5 369 351 346 
 
C 3 357 334 
 E 1 307  
F 7 286 287 292 290 
G 5 345 344 345 
 
H 3 308 304 
 J 1 306  
K 7 305 301 321 309 
L 5 359 350 348 
 
M 3 334 343 
 N 1 299  
O 7 296 276 274 292 
P 5 335 349 349 
 
Q 3 350 344 
 R 1 313  
S 7 303 314 300 319 
T 5 312 319 318 
 
U 3 384 369 
 V 1 305  
W 7 350 337 341 332 
X 5 317 323 320 
 
Y 3 312 304 
 Z 1 298  
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 Part 2: Linear Measurements, Coronal Section, Control Side 
specimen group 
Buccal 
height 
Palatal 
height 
Total  
ridge 
width 
1 12 2.298 1.865 3.383 
2 10 0 2.139 2.584 
3 12 2.466 1.964 3.222 
4 10 2.412 1.757 3.281 
5 12 1.675 1.744 3.228 
6 10 2.41 1.946 3.224 
7 12 2.265 1.594 3.357 
8 10 2.561 1.855 3.478 
9 12 2.542 2.11 3.269 
10 10 2.455 1.55 3.406 
11 12 2.463 1.829 3.256 
12 10 2.61 2.079 3.287 
13 12 2.346 1.8 3.386 
14 10 2.269 2.004 3.474 
15 10 2.487 2.197 3.223 
16 12 2.444 1.752 3.402 
17 12 2.324 1.775 3.034 
 
99 
 
 
Part 2: Linear Measurements, Sagittal Section, Control Side 
specimen group 
CEJ to AC 
distal to m2 mesial to m2 
1 12 0.762 0.413 
2 10 0.451 0.416 
3 12 0.643 0.69 
4 10 0.364 0.436 
5 12 0.421 0.528 
6 10 0.436 0.475 
7 12 0.553 0.331 
8 10 0.845 0.359 
9 12 0.351 0.404 
10 10 0.611 0.851 
11 12 0.653 0.505 
12 10 0.436 0.25 
13 12 0.306 0.436 
14 10 0.641 0.289 
15 10 0.407 0.491 
16 12 0.409 0.326 
17 12 0.276 0.354 
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 Part 2: Volumetric Measurements, Coronal Section, Control Side 
specimen group 
area mean 
BMD BV/TV BS/TV total buccal palatal 
1 12 6.329 3.103 3.248 1.40117 57.5731 45.84361 
2 10 5.102 3.402 1.882 1.39402 51.15794 46.74146 
3 12 6.449 2.772 3.743 1.40258 63.9758 37.50658 
4 10 6.123 2.886 3.126 1.40601 42.25889 39.3351 
5 12 5.398 2.448 2.913 1.38282 62.85683 42.6149 
6 10 6.379 3.184 3.205 1.36139 55.3298 44.1857 
7 12 5.861 2.661 3.276 1.37875 53.47056 44.56749 
8 10 7.066 3.297 3.908 1.37672 65.44681 40.13952 
9 12 7.175 3.239 3.743 1.36055 34.97243 40.01729 
10 10 5.996 2.994 2.837 1.38986 68.05284 38.18254 
11 12 6.684 3.425 3.381 1.34022 72.71868 36.81418 
12 10 6.805 3.378 3.649 1.35889 60.2007 40.6264 
13 12 6.162 2.891 3.299 1.38157 52.27509 41.16002 
14 10 6.802 3.458 3.263 1.34021 52.46548 45.28456 
15 10 6.997 3.489 3.467 1.3772 69.7224 59.16701 
16 12 6.487 3.442 3.024 1.39785 59.29264 45.19325 
17 12 6.02 2.913 3.269 1.38105 44.57904 41.48087 
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Part 2: Linear Measurements, Coronal Section, Experimental Side 
specimen group 
Buccal 
height 
Palatal 
height 
Total 
ridge 
width 
1 11 1.787 1.732 3.621 
2 9 1.865 1.588 3.425 
3 11 1.957 1.708 3.391 
4 9 1.492 1.383 3.009 
5 11 1.647 1.595 3.418 
6 9 2.124 1.905 3.374 
7 11 1.904 1.165 3.326 
8 9 1.832 1.47 3.325 
9 11 2.176 1.618 3.271 
10 9 1.981 1.034 3.737 
11 11 1.921 1.392 3.59 
12 9 1.917 1.599 3.313 
13 11 1.953 1.483 3.643 
14 9 2.744 1.627 3.832 
15 9 2.023 1.202 3.654 
16 11 2.152 1.379 3.279 
17 11 2.705 1.417 3.476 
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Part 2: Linear Measurements, Sagittal Section, Experimental Side 
specimen group 
CEJ to AC 
distal to m2 mesial to m2 
1 11 0.437 0.607 
2 9 0.45 0.716 
3 11 0.802 0.604 
4 9 0.402 0.865 
5 11 0.339 0.611 
6 9 0.407 0.904 
7 11 0.363 0.728 
8 9 0.575 0.864 
9 11 0.335 0.469 
10 9 0.697 2.055 
11 11 0.407 1.013 
12 9 0.393 0.714 
13 11 0.773 0.54 
14 9 0.597 1.067 
15 9 0.467 1.424 
16 11 0.647 0.58 
17 11 0.29 1.273 
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Part 2: Volumetric Measurements, Coronal Section, Experimental Side 
specimen group mean BMD BV TV BV/TV BS/TV 
1 11 1.55894 0.03153 0.05336 59.08658 62.87701 
2 9 1.40916 0.01684 0.05333 31.58410 26.20168 
3 11 1.46077 0.02979 0.05336 55.8235 44.214 
4 9 1.51149 0.03811 0.05334 71.44124 27.38097 
5 11 1.51077 0.03232 0.05335 60.58481 43.82793 
6 9 1.28565 0.03604 0.05335 67.55899 32.34835 
7 11 1.44444 0.03298 0.05334 61.83137 67.29622 
8 9 1.46405 0.02625 0.05331 49.24345 44.9193 
9 11 1.37079 0.02872 0.05333 66.90113 36.02535 
10 9 1.3882 0.0479 0.05330 89.85745 26.95086 
11 11 1.46486 0.02713 0.05333 50.87565 36.42129 
12 9 1.51203 0.03521 0.05336 65.98290 32.63277 
13 11 1.50497 0.02968 0.05336 55.62899 44.0692 
14 9 1.50056 0.05063 0.05333 94.93382 20.2442 
15 9 1.53945 0.02724 0.05329 51.45704 41.42747 
16 11 1.48606 0.03268 0.05328 61.34513 44.42881 
17 11 1.38359 0.04655 0.05334 87.28354 60.61967 
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Part 2: Weight Measurements 
specimen group 
weight (g) 
0 day 7 day 14 day 28 day 
1 11 309 319 310 313 
2 9 302 300 304 305 
3 11 329 313 309 306 
4 9 296 287 300 314 
5 11 304 296 303 305 
6 9 356 343 341 328 
7 11 257 266 284 263 
8 9 304 298 293 296 
9 11 299 317 322 307 
10 9 316 314 329 338 
11 11 342 336 340 335 
12 9 294 285 310 309 
13 11 327 330 347 328 
14 9 327 340 335 331 
15 9 308 303 304 296 
16 11 303 300 299 305 
17 11 289 305 310 301 
 
 
 
